4. REFERENCES
1.Schafer, W., et al. Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn, 2002. 21: 261.
https://pubmed.ncbi.nlm.nih.gov/11948720/
2.Abrams, P., et al. Reviewing the ICS 2002 terminology report: the ongoing debate. Neurourol Urodyn, 2009. 28: 287.
https://pubmed.ncbi.nlm.nih.gov/19350662/
3.Abrams, P., et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn, 2002. 21: 167.
https://pubmed.ncbi.nlm.nih.gov/11857671/
4.Groen, J., et al. Summary of European Association of Urology (EAU) Guidelines on Neuro-Urology. Eur Urol, 2015.
https://pubmed.ncbi.nlm.nih.gov/26304502/
5.Nosseir, M., et al. Clinical usefulness of urodynamic assessment for maintenance of bladder function in patients with spinal cord injury. Neurourol Urodyn, 2007. 26: 228.
https://pubmed.ncbi.nlm.nih.gov/16998859/
6.Panicker, J.N., et al. Lower urinary tract dysfunction in the neurological patient: clinical assessment and management. Lancet Neurol, 2015. 14: 720.
https://pubmed.ncbi.nlm.nih.gov/26067125/
7.Guyatt, G.H., et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ, 2008. 336: 924.
https://pubmed.ncbi.nlm.nih.gov/18436948/
8.Guyatt, G.H., et al. What is “quality of evidence” and why is it important to clinicians? BMJ, 2008. 336: 995.
https://pubmed.ncbi.nlm.nih.gov/18456631/
9.Phillips B, et al. Oxford Centre for Evidence-based Medicine Levels of Evidence. Updated by Jeremy Howick March 2009. 1998.
https://www.cebm.net/2009/06/oxford-centre-evidence-based-medicine-levels-evidence-march-2009/
10.Guyatt, G.H., et al. Going from evidence to recommendations. BMJ, 2008. 336: 1049.
https://pubmed.ncbi.nlm.nih.gov/18467413/
11.Townsend, N., et al. Cardiovascular disease in Europe - epidemiological update 2015. Eur Heart J, 2015.
https://pubmed.ncbi.nlm.nih.gov/26306399/
12.Tibaek, S., et al. Prevalence of lower urinary tract symptoms (LUTS) in stroke patients: a cross-sectional, clinical survey. Neurourol Urodyn, 2008. 27: 763.
https://pubmed.ncbi.nlm.nih.gov/18551565/
13.Marinkovic, S.P., et al. Voiding and sexual dysfunction after cerebrovascular accidents. J Urol, 2001. 165: 359.
https://pubmed.ncbi.nlm.nih.gov/11176374/
14.Rotar, M., et al. Stroke patients who regain urinary continence in the first week after acute first-ever stroke have better prognosis than patients with persistent lower urinary tract dysfunction. Neurourol Urodyn, 2011. 30: 1315.
https://pubmed.ncbi.nlm.nih.gov/21488096/
15.Lobo, A., et al. Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology, 2000. 54: S4.
https://pubmed.ncbi.nlm.nih.gov/10854354/
16.Na, H.R., et al. Urinary incontinence in Alzheimer’s disease is associated with Clinical Dementia Rating-Sum of Boxes and Barthel Activities of Daily Living. Asia Pac Psychiatry, 2015. 7: 113.
https://pubmed.ncbi.nlm.nih.gov/23857871/
17.Grant, R.L., et al. First diagnosis and management of incontinence in older people with and without dementia in primary care: a cohort study using The Health Improvement Network primary care database. PLoS Med, 2013. 10: e1001505.
https://pubmed.ncbi.nlm.nih.gov/24015113/
18.Pringsheim, T., et al. The prevalence of Parkinson’s disease: a systematic review and meta-analysis. Mov Disord, 2014. 29: 1583.
https://pubmed.ncbi.nlm.nih.gov/24976103/
19.Picillo, M., et al. The PRIAMO study: urinary dysfunction as a marker of disease progression in early Parkinson’s disease. Eur J Neurol, 2017. 24: 788.
https://pubmed.ncbi.nlm.nih.gov/28425642/
20.Papatsoris, A.G., et al. Urinary and erectile dysfunction in multiple system atrophy (MSA). Neurourol Urodyn, 2008. 27: 22.
https://pubmed.ncbi.nlm.nih.gov/17563111/
21.Kim, M., et al. Impaired detrusor contractility is the pathognomonic urodynamic finding of multiple system atrophy compared to idiopathic Parkinson’s disease. Parkinsonism Relat Disord, 2015. 21: 205.
https://pubmed.ncbi.nlm.nih.gov/25534084/
22.Sakakibara, R., et al. A guideline for the management of bladder dysfunction in Parkinson’s disease and other gait disorders. Neurourol Urodyn, 2015.
https://pubmed.ncbi.nlm.nih.gov/25810035/
23.Yamamoto, T., et al. Postvoid residual predicts the diagnosis of multiple system atrophy in Parkinsonian syndrome. J Neurol Sci, 2017. 381: 230.
https://pubmed.ncbi.nlm.nih.gov/28991688/
24.Dolecek, T.A., et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro Oncol, 2012. 14 Suppl 5: v1.
https://pubmed.ncbi.nlm.nih.gov/23095881/
25.Maurice-Williams, R.S. Micturition symptoms in frontal tumours. J Neurol Neurosurg Psychiatry, 1974. 37: 431.
https://pubmed.ncbi.nlm.nih.gov/4365244/
26.Christensen, D., et al. Prevalence of cerebral palsy, co-occurring autism spectrum disorders, and motor functioning - Autism and Developmental Disabilities Monitoring Network, USA, 2008. Dev Med Child Neurol, 2014. 56: 59.
https://pubmed.ncbi.nlm.nih.gov/24117446/
27.Samijn, B., et al. Lower urinary tract symptoms and urodynamic findings in children and adults with cerebral palsy: A systematic review. Neurourol Urodyn, 2017. 36: 541.
https://pubmed.ncbi.nlm.nih.gov/26894322/
28.Tagliaferri, F., et al. A systematic review of brain injury epidemiology in Europe. Acta Neurochir (Wien), 2006. 148: 255.
https://pubmed.ncbi.nlm.nih.gov/16311842/
29.Kulakli, F., et al. Relationship between urinary dysfunction and clinical factors in patients with traumatic brain injury. Brain Inj, 2014. 28: 323.
https://pubmed.ncbi.nlm.nih.gov/24377376/
30.Aruga, S., et al. Effect of cerebrospinal fluid shunt surgery on lower urinary tract dysfunction in idiopathic normal pressure hydrocephalus. Neurourol Urodyn, 2018. 37: 1053.
https://pubmed.ncbi.nlm.nih.gov/28892272/
31.Singh, A., et al. Global prevalence and incidence of traumatic spinal cord injury. Clin Epidemiol, 2014. 6: 309.
https://pubmed.ncbi.nlm.nih.gov/25278785/
32.Weld, K.J., et al. Association of level of injury and bladder behavior in patients with post-traumatic spinal cord injury. Urology, 2000. 55: 490.
https://pubmed.ncbi.nlm.nih.gov/10736489/
33.Kondo, A., et al. Neural tube defects: prevalence, etiology and prevention. Int J Urol, 2009. 16: 49.
https://pubmed.ncbi.nlm.nih.gov/19120526/
34.Sawin, K.J., et al. The National Spina Bifida Patient Registry: profile of a large cohort of participants from the first 10 clinics. J Pediatr, 2015. 166: 444.
https://pubmed.ncbi.nlm.nih.gov/25444012/
35.Wiener, J.S., et al. Bladder Management and Continence Outcomes in Adults with Spina Bifida: Results from the National Spina Bifida Patient Registry, 2009 to 2015. J Urol, 2018. 200: 187.
https://pubmed.ncbi.nlm.nih.gov/29588216/
36.Peyronnet, B., et al. Comparison of neurogenic lower urinary tract dysfunctions in open versus closed spinal dysraphism: A prospective cross-sectional study of 318 patients. Neurourol Urodyn, 2018. 37: 2818.
https://pubmed.ncbi.nlm.nih.gov/30070396/
37.Joussain, C., et al. Urological dysfunction in patients with hereditary spastic paraplegia. Neurourol Urodyn, 2019. 38: 1081.
https://pubmed.ncbi.nlm.nih.gov/30848841/
38.Bartolin, Z., et al. Relationship between clinical data and urodynamic findings in patients with lumbar intervertebral disk protrusion. Urol Res, 2002. 30: 219.
https://pubmed.ncbi.nlm.nih.gov/12202938/
39.Baker, M., et al. Urogenital symptoms in women with Tarlov cysts. J Obstet Gynaecol Res, 2018. 44: 1817.
https://pubmed.ncbi.nlm.nih.gov/29974579/
40.Lange, M.M., et al. Urinary and sexual dysfunction after rectal cancer treatment. Nat Rev Urol, 2011. 8: 51.
https://pubmed.ncbi.nlm.nih.gov/21135876/
41.International Diabetes Federation, IDF Diabetes Atlas, 6th edn. 2013, International Diabetes Federation: Brussels, Belgium.
42.Yuan, Z., et al. Diabetic cystopathy: A review. J Diabetes, 2015. 7: 442.
https://pubmed.ncbi.nlm.nih.gov/25619174/
43.Pugliatti, M., et al. The epidemiology of multiple sclerosis in Europe. Eur J Neurol, 2006. 13: 700.
https://pubmed.ncbi.nlm.nih.gov/16834700/
44.de Seze, M., et al. The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines. Mult Scler, 2007. 13: 915.
https://pubmed.ncbi.nlm.nih.gov/17881401/
45.Al Dandan, H.B., et al. Prevalence of Lower Urinary Tract Symptoms in People with Multiple Sclerosis: A Systematic Review and Meta-analysis. Int J MS Care, 2020. 22: 91.
https://pubmed.ncbi.nlm.nih.gov/32410904/
46.Gajewski, J.B., et al. An International Continence Society (ICS) report on the terminology for adult neurogenic lower urinary tract dysfunction (ANLUTD). Neurourol Urodyn, 2018. 37: 1152.
https://pubmed.ncbi.nlm.nih.gov/29149505/
47.Fadrique, G.G., et al. Urodynamic Differences between Complete and Incomplete Spinal Cord Injuries with Neurogenic Detrusor Overactivity. Urol Int, 2020. 104: 273.
https://pubmed.ncbi.nlm.nih.gov/31461727/
48.Ahlberg, J., et al. Neurological signs are common in patients with urodynamically verified “idiopathic” bladder overactivity. Neurourol Urodyn, 2002. 21: 65.
https://pubmed.ncbi.nlm.nih.gov/11835426/
49.Borau, A., et al. A systematic review of the diagnosis and treatment of patients with neurogenic hyperactivity of the detrusor muscle. Actas Urol Esp, 2018. 42: 5.
https://pubmed.ncbi.nlm.nih.gov/28413135/
50.Musco, S., et al. Value of urodynamic findings in predicting upper urinary tract damage in neuro-urological patients: A systematic review. Neurourol Urodyn, 2018.
https://pubmed.ncbi.nlm.nih.gov/29392753/
51.Bors, E., et al. History and physical examination in neurological urology. J Urol, 1960. 83: 759.
https://pubmed.ncbi.nlm.nih.gov/13802958/
52.Cameron, A.P., et al. The Severity of Bowel Dysfunction in Patients with Neurogenic Bladder. J Urol, 2015.
https://pubmed.ncbi.nlm.nih.gov/25956470/
53.Vodusek, D.B. Lower urinary tract and sexual dysfunction in neurological patients. Eur Neurol, 2014. 72: 109.
https://pubmed.ncbi.nlm.nih.gov/24993182/
54.Linsenmeyer, T.A., et al. Accuracy of individuals with spinal cord injury at predicting urinary tract infections based on their symptoms. J Spinal Cord Med, 2003. 26: 352.
https://pubmed.ncbi.nlm.nih.gov/14992336/
55.Massa, L.M., et al. Validity, accuracy, and predictive value of urinary tract infection signs and symptoms in individuals with spinal cord injury on intermittent catheterization. J Spinal Cord Med, 2009. 32: 568.
https://pubmed.ncbi.nlm.nih.gov/20025153/
56.Konstantinidis, C., et al. Optimal bladder diary duration for patients with suprapontine neurogenic lower urinary tract dysfunction. Int Braz J Urol, 2016. 42: 766.
https://pubmed.ncbi.nlm.nih.gov/27564288/
57.Henze, T. Managing specific symptoms in people with multiple sclerosis. Int MS J, 2005. 12: 60.
https://pubmed.ncbi.nlm.nih.gov/16417816/
58.Myers, J.B., et al. Patient reported bladder-related symptoms and quality of life after spinal cord injury with different bladder management strategies. J Urol, 2019. 202: 574.
https://pubmed.ncbi.nlm.nih.gov/30958741/
59.Moghalu, O., et al. Psychosocial aspects of health-related quality of life and the association with patient-reported bladder symptoms and satisfaction after spinal cord injury. Spinal Cord, 2021.
https://pubmed.ncbi.nlm.nih.gov/33495582/
60.Khalaf, K.M., et al. The impact of lower urinary tract symptoms on health-related quality of life among patients with multiple sclerosis. Neurourol Urodyn, 2016. 35: 48.
https://pubmed.ncbi.nlm.nih.gov/25327401/
61.Szymanski, K.M., et al. All Incontinence is Not Created Equal: Impact of Urinary and Fecal Incontinence on Quality of Life in Adults with Spina Bifida. J Urol, 2017. Part 2. 197: 885.
https://pubmed.ncbi.nlm.nih.gov/28131501/
62.Pannek, J., et al. Does optimizing bladder management equal optimizing quality of life? Correlation between health-related quality of life and urodynamic parameters in patients with spinal cord lesions. Urology, 2009. 74: 263.
https://pubmed.ncbi.nlm.nih.gov/19428089/
63.Patel, D.P., et al. Patient reported outcomes measures in neurogenic bladder and bowel: A systematic review of the current literature. Neurourol Urodyn, 2016. 35: 8.
https://pubmed.ncbi.nlm.nih.gov/25327455/
64.Bonniaud, V., et al. Qualiveen, a urinary-disorder specific instrument: 0.5 corresponds to the minimal important difference. J Clin Epidemiol, 2008. 61: 505.
https://pubmed.ncbi.nlm.nih.gov/18394545/
65.Bonniaud, V., et al. Development and validation of the short form of a urinary quality of life questionnaire: SF-Qualiveen. J Urol, 2008. 180: 2592.
https://pubmed.ncbi.nlm.nih.gov/18950816/
66.Best, K.L., et al. Identifying and classifying quality of life tools for neurogenic bladder function after spinal cord injury: A systematic review. J Spinal Cord Med, 2017. 40: 505.
https://pubmed.ncbi.nlm.nih.gov/27734771/
67.Welk, B., et al. The Neurogenic Bladder Symptom Score (NBSS): A secondary assessment of its validity, reliability among people with a spinal cord injury. Spinal Cord, 2018. 56: 259.
https://pubmed.ncbi.nlm.nih.gov/29184133/
68.Welk, B., et al. The creation and validation of a short form of the Neurogenic Bladder Symptom Score. Neurourol Urodyn, 2020. 39: 1162.
https://pubmed.ncbi.nlm.nih.gov/32196732/
69.Pariser, J.J., et al. Reliability and Validity of the Neurogenic Bladder Symptom Score in Adults with Cerebral Palsy. Urology, 2019. 128: 107.
https://pubmed.ncbi.nlm.nih.gov/30890419/
70.Gulick, E.E. Bowel management related quality of life in people with multiple sclerosis: psychometric evaluation of the QoL-BM measure. Int J Nurs Stud, 2011. 48: 1066.
https://pubmed.ncbi.nlm.nih.gov/21377677/
71.Turmel, N., et al. Lower urinary tract symptoms treatment constraints assessment (LUTS-TCA): a new tool for a global evaluation of neurogenic bladder treatments. World J Urol, 2019. 37: 1917.
https://pubmed.ncbi.nlm.nih.gov/30511213/
72.Trachtenberg, R.E., et al. Clinical Profiles and Symptom Burden Estimates to Support Decision-Making Using the Urinary Symptom Questionnaire for People with Neurogenic Bladder (USQNB) using Intermittent Catheters. PM R, 2021. 13: 229.
https://pubmed.ncbi.nlm.nih.gov/32860333/
73.Foley, F.W., et al. The Multiple Sclerosis Intimacy and Sexuality Questionnaire -- re-validation and development of a 15-item version with a large US sample. Mult Scler, 2013. 19: 1197.
https://pubmed.ncbi.nlm.nih.gov/23369892/
74.Sanders, A.S., et al. The Multiple Sclerosis Intimacy and Sexuality Questionnaire-19 (MSISQ-19). Sex Disabil, 2000. 18: 3.
https://www.med-iq.com/files/noncme/material/pdfs/MSISQ-191.pdf
75.‘t Hoen, A., et al. A Quality Assessment of Patient-Reported Outcome Measures for Sexual Function in Neurologic Patients Using the Consensus-based Standards for the Selection of Health Measurement Instruments Checklist: A Systematic Review. Eur Urol Focus, 2016.
https://pubmed.ncbi.nlm.nih.gov/28753768/
76.Tsang, B., et al. A systematic review and comparison of questionnaires in the management of spinal cord injury, multiple sclerosis and the neurogenic bladder. Neurourol Urodyn, 2015.
https://pubmed.ncbi.nlm.nih.gov/25620137/
77.Schurch, B., et al. Reliability and validity of the Incontinence Quality of Life questionnaire in patients with neurogenic urinary incontinence. Arch Phys Med Rehabil, 2007. 88: 646.
https://pubmed.ncbi.nlm.nih.gov/17466735/
78.Hollingworth, W., et al. Exploring the impact of changes in neurogenic urinary incontinence frequency and condition-specific quality of life on preference-based outcomes. Qual Life Res, 2010. 19: 323.
https://pubmed.ncbi.nlm.nih.gov/20094804/
79.Cella, D.F., et al. Validation of the functional assessment of multiple sclerosis quality of life instrument. Neurology, 1996. 47: 129.
https://pubmed.ncbi.nlm.nih.gov/8710066/
80.Wesson, J.M., et al. The functional index for living with multiple sclerosis: development and validation of a new quality of life questionnaire. Mult Scler, 2009. 15: 1239.
https://pubmed.ncbi.nlm.nih.gov/19737850/
81.Gold, S.M., et al. Disease specific quality of life instruments in multiple sclerosis: validation of the Hamburg Quality of Life Questionnaire in Multiple Sclerosis (HAQUAMS). Mult Scler, 2001. 7: 119.
https://pubmed.ncbi.nlm.nih.gov/11424632/
82.Goodin, D.S. A questionnaire to assess neurological impairment in multiple sclerosis. Mult Scler, 1998. 4: 444.
https://pubmed.ncbi.nlm.nih.gov/9839306/
83.Marrie, R.A., et al. Validity and reliability of the MSQLI in cognitively impaired patients with multiple sclerosis. Mult Scler, 2003. 9: 621.
https://pubmed.ncbi.nlm.nih.gov/14664477/
84.Vickrey, B.G., et al. A health-related quality of life measure for multiple sclerosis. Qual Life Res, 1995. 4: 187.
https://pubmed.ncbi.nlm.nih.gov/7613530/
85.Honan, C.A., et al. The multiple sclerosis work difficulties questionnaire (MSWDQ): development of a shortened scale. Disabil Rehabil, 2014. 36: 635.
https://pubmed.ncbi.nlm.nih.gov/23786346/
86.Bonniaud, V., et al. Measuring quality of life in multiple sclerosis patients with urinary disorders using the Qualiveen questionnaire. Arch Phys Med Rehabil, 2004. 85: 1317.
https://pubmed.ncbi.nlm.nih.gov/15295759/
87.Franceschini, M., et al. Follow-up in persons with traumatic spinal cord injury: questionnaire reliability. Eura Medicophys, 2006. 42: 211.
https://pubmed.ncbi.nlm.nih.gov/17039217/
88.Noreau, L., et al. Development and assessment of a community follow-up questionnaire for the Rick Hansen spinal cord injury registry. Arch Phys Med Rehabil, 2013. 94: 1753.
https://pubmed.ncbi.nlm.nih.gov/23529142/
89.Husmann, D.A. Mortality following augmentation cystoplasty: A transitional urologist’s viewpoint.
J Pediatr Urol, 2017.
https://pubmed.ncbi.nlm.nih.gov/28645552/
90.Yang, C.C., et al. Bladder management in women with neurologic disabilities. Phys Med Rehabil Clin N Am, 2001. 12: 91.
https://pubmed.ncbi.nlm.nih.gov/11853041/
91.Podnar, S., et al. Protocol for clinical neurophysiologic examination of the pelvic floor. Neurourol Urodyn, 2001. 20: 669.
https://pubmed.ncbi.nlm.nih.gov/11746548/
92.Harrison, S., et al. Urinary incontinence in neurological disease: assessment and management. NICE Clinical Guideline 2012. [CG148].
https://www.nice.org.uk/guidance/cg148
93.Krassioukov, A., et al. International standards to document remaining autonomic function after spinal cord injury. J Spinal Cord Med, 2012. 35: 201.
https://pubmed.ncbi.nlm.nih.gov/22925746/
94.Liu, N., et al. Autonomic dysreflexia severity during urodynamics and cystoscopy in individuals with spinal cord injury. Spinal Cord, 2013. 51: 863.
https://pubmed.ncbi.nlm.nih.gov/24060768/
95.Labat, J.J., et al. Diagnostic criteria for pudendal neuralgia by pudendal nerve entrapment (Nantes criteria). Neurourol Urodyn, 2008. 27: 306.
https://pubmed.ncbi.nlm.nih.gov/17828787/
96.Brown, D., Atlas of regional anesthesia. 3rd. ed. 2006, Philadelphia
97.Standring, S., Gray’s anatomy, 40th ed. 2008.
98.Bellucci, C.H., et al. Neurogenic lower urinary tract dysfunction--do we need same session repeat urodynamic investigations? J Urol, 2012. 187: 1318.
https://pubmed.ncbi.nlm.nih.gov/22341264/
99.Walter, M., et al. Autonomic dysreflexia and repeatability of cardiovascular changes during same session repeat urodynamic investigation in women with spinal cord injury. World J Urol, 2015.
https://pubmed.ncbi.nlm.nih.gov/26055644/
100.Walter, M., et al. Prediction of autonomic dysreflexia during urodynamics: A prospective cohort study. BMC Med, 2018. 16: 53.
https://pubmed.ncbi.nlm.nih.gov/29650001/
101.Gammie, A., et al. International Continence Society guidelines on urodynamic equipment performance. Neurourol Urodyn, 2014. 33: 370.
https://pubmed.ncbi.nlm.nih.gov/24390971/
102.McGuire, E.J., et al. Leak-point pressures. Urol Clin North Am, 1996. 23: 253.
https://pubmed.ncbi.nlm.nih.gov/8659025/
103.Ozkan, B., et al. Which factors predict upper urinary tract deterioration in overactive neurogenic bladder dysfunction? Urology, 2005. 66: 99.
https://pubmed.ncbi.nlm.nih.gov/15992868/
104.Wang, Q.W., et al. Is it possible to use urodynamic variables to predict upper urinary tract dilatation in children with neurogenic bladder-sphincter dysfunction? BJU Int, 2006. 98: 1295.
https://pubmed.ncbi.nlm.nih.gov/17034510/
105.Linsenmeyer, T.A., et al. The impact of urodynamic parameters on the upper tracts of spinal cord injured men who void reflexly. J Spinal Cord Med, 1998. 21: 15.
https://pubmed.ncbi.nlm.nih.gov/9541882/
106.McGuire, E.J., et al. Prognostic value of urodynamic testing in myelodysplastic patients. J Urol, 1981. 126: 205.
https://pubmed.ncbi.nlm.nih.gov/7196460/
107.Krongrad, A., et al. Bladder neck dysynergia in spinal cord injury. Am J Phys Med Rehabil, 1996.
75: 204.
https://pubmed.ncbi.nlm.nih.gov/8663928/
108.Weld, K.J., et al. Clinical significance of detrusor sphincter dyssynergia type in patients with post-traumatic spinal cord injury. Urology, 2000. 56: 565.
https://pubmed.ncbi.nlm.nih.gov/11018603/
109.Rossier, A.B., et al. 5-microtransducer catheter in evaluation of neurogenic bladder function. Urology, 1986. 27: 371.
https://pubmed.ncbi.nlm.nih.gov/3962062/
110.Al-Ali, M., et al. A 10 year review of the endoscopic treatment of 125 spinal cord injured patients with vesical outlet obstruction: does bladder neck dyssynergia exist? Paraplegia, 1996. 34: 34.
https://pubmed.ncbi.nlm.nih.gov/8848321/
111.Bacsu, C.D., et al. Diagnosing detrusor sphincter dyssynergia in the neurological patient. BJU Int, 2012. 109 Suppl 3: 31.
https://pubmed.ncbi.nlm.nih.gov/22458490/
112.Lose, G., et al. Standardisation of urethral pressure measurement: report from the Standardisation Sub-Committee of the International Continence Society. Neurourol Urodyn, 2002. 21: 258.
https://pubmed.ncbi.nlm.nih.gov/11948719/
113.Marks, B.K., et al. Videourodynamics: indications and technique. Urol Clin North Am, 2014. 41: 383.
https://pubmed.ncbi.nlm.nih.gov/25063594/
114.Virseda, M., et al. Reliability of ambulatory urodynamics in patients with spinal cord injuries. Neurourol Urodyn, 2013. 32: 387.
https://pubmed.ncbi.nlm.nih.gov/23002043/
115.Virseda-Chamorro, M., et al. Comparison of ambulatory versus video urodynamics in patients with spinal cord injury. Spinal Cord, 2014. 52: 551.
https://pubmed.ncbi.nlm.nih.gov/24663000/
116.Geirsson, G., et al. The ice-water test--a simple and valuable supplement to routine cystometry.
Br J Urol, 1993. 71: 681.
https://pubmed.ncbi.nlm.nih.gov/8343894/
117.Geirsson, G., et al. Pressure, volume and infusion speed criteria for the ice-water test. Br J Urol, 1994. 73: 498.
https://pubmed.ncbi.nlm.nih.gov/8012770/
118.Kozomara, M., et al. Is Detrusor Contraction during Rapid Bladder Filling Caused by Cold or Warm Water? A Randomized, Controlled, Double-Blind Trial. J Urol, 2018. 199: 223.
https://pubmed.ncbi.nlm.nih.gov/28751267/
119.Al-Hayek, S., et al. The 50-year history of the ice water test in urology. J Urol, 2010. 183: 1686.
https://pubmed.ncbi.nlm.nih.gov/20299050/
120.Lapides, J. Neurogenic bladder. Principles of treatment. Urol Clin North Am, 1974. 1: 81.
https://pubmed.ncbi.nlm.nih.gov/4428540/
121.Riedl, C.R., et al. Electromotive administration of intravesical bethanechol and the clinical impact on acontractile detrusor management: introduction of a new test. J Urol, 2000. 164: 2108.
https://pubmed.ncbi.nlm.nih.gov/11061937/
122.Podnar, S., et al. Lower urinary tract dysfunction in patients with peripheral nervous system lesions. Handb Clin Neurol, 2015. 130: 203.
https://pubmed.ncbi.nlm.nih.gov/26003246/
123.Ouyang, L., et al. Characteristics and survival of patients with end stage renal disease and spina bifida in the United States renal data system. J Urol, 2015. 193: 558.
https://pubmed.ncbi.nlm.nih.gov/25167993/
124.Lane, G.I., et al. Clinical outcomes of non-surgical management of detrusor leak point pressures above 40 cm water in adults with congenital neurogenic bladder. Neurourol Urodyn, 2018. 37: 1943.
https://pubmed.ncbi.nlm.nih.gov/29488655/
125.Lawrenson, R., et al. Renal failure in patients with neurogenic lower urinary tract dysfunction. Neuroepidemiology, 2001. 20: 138.
https://pubmed.ncbi.nlm.nih.gov/11359083/
126.Dangle, P.P., et al. Cystatin C-calculated Glomerular Filtration Rate-A Marker of Early Renal Dysfunction in Patients With Neuropathic Bladder. Urology, 2017. 100: 213.
https://pubmed.ncbi.nlm.nih.gov/27542858/
127.Mingat, N., et al. Prospective study of methods of renal function evaluation in patients with neurogenic bladder dysfunction. Urology, 2013. 82: 1032.
https://pubmed.ncbi.nlm.nih.gov/24001705/
128.Averbeck, M.A., et al. Follow-up of the neuro-urological patient: a systematic review. BJU Int, 2015. 115 Suppl 6: 39.
https://pubmed.ncbi.nlm.nih.gov/25891319/
129.Stöhrer, M., et al. Diagnosis and treatment of bladder dysfunction in spinal cord injury patients. Eur Urol Update Series, 1994. 3: 170. [No abstract available].
130.Apostolidis, A., et al., Neurologic Urinary and Faecal Incontinence, in Incontinence 6th Edition,
P. Abrams, L. Cardozo, S. Khoury & A. Wein, Editors. 2017.
131.Chamberlain, J.D., et al. Mortality and longevity after a spinal cord injury: systematic review and meta-analysis. Neuroepidemiology, 2015. 44: 182.
https://pubmed.ncbi.nlm.nih.gov/25997873/
132.Game, X., et al. Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections. Eur Urol, 2008. 53: 613.
https://pubmed.ncbi.nlm.nih.gov/17804150/
133.Frankel, H.L., et al. Long-term survival in spinal cord injury: a fifty year investigation. Spinal Cord, 1998. 36: 266.
https://pubmed.ncbi.nlm.nih.gov/9589527/
134.Jamil, F. Towards a catheter free status in neurogenic bladder dysfunction: a review of bladder management options in spinal cord injury (SCI). Spinal Cord, 2001. 39: 355.
https://pubmed.ncbi.nlm.nih.gov/11464308/
135.Thietje, R., et al. Mortality in patients with traumatic spinal cord injury: descriptive analysis of
62 deceased subjects. J Spinal Cord Med, 2011. 34: 482.
https://pubmed.ncbi.nlm.nih.gov/22118255/
136.Hackler, R.H. A 25-year prospective mortality study in the spinal cord injured patient: comparison with the long-term living paraplegic. J Urol, 1977. 117: 486.
https://pubmed.ncbi.nlm.nih.gov/850323/
137.Rodrigues, P., et al. Involuntary detrusor contraction is a frequent finding in patients with recurrent urinary tract infections. Urol Int, 2014. 93: 67.
https://pubmed.ncbi.nlm.nih.gov/25011551/
138.Bauer, S.B. Neurogenic bladder: etiology and assessment. Pediatr Nephrol, 2008. 23: 541.
https://pubmed.ncbi.nlm.nih.gov/18270749/
139.Barbalias, G.A., et al. Critical evaluation of the Crede maneuver: a urodynamic study of 207 patients. J Urol, 1983. 130: 720.
https://pubmed.ncbi.nlm.nih.gov/6887405/
140.Reinberg, Y., et al. Renal rupture after the Crede maneuver. J Pediatr, 1994. 124: 279.
https://pubmed.ncbi.nlm.nih.gov/8301439/
141.Wyndaele, J.J., et al. Neurologic urinary incontinence. Neurourol Urodyn, 2010. 29: 159.
https://pubmed.ncbi.nlm.nih.gov/20025021/
142.Menon, E.B., et al. Bladder training in patients with spinal cord injury. Urology, 1992. 40: 425.
https://pubmed.ncbi.nlm.nih.gov/1441039/
143.Furusawa, K., et al. Incidence of symptomatic autonomic dysreflexia varies according to the bowel and bladder management techniques in patients with spinal cord injury. Spinal Cord, 2011. 49: 49.
https://pubmed.ncbi.nlm.nih.gov/20697419/
144.Outcomes following traumatic spinal cord injury: clinical practice guidelines for health-care professionals. J Spinal Cord Med, 2000. 23: 289.
https://pubmed.ncbi.nlm.nih.gov/17536300/
145.El-Masri, W.S., et al. Long-term follow-up study of outcomes of bladder management in spinal cord injury patients under the care of the Midlands Centre for Spinal Injuries in Oswestry. Spinal Cord, 2012. 50: 14.
https://pubmed.ncbi.nlm.nih.gov/21808256/
146.Fall, M., et al. Electrical stimulation. A physiologic approach to the treatment of urinary incontinence. Urol Clin North Am, 1991. 18: 393.
https://pubmed.ncbi.nlm.nih.gov/2017820/
147.Vodusek, D.B., et al. Detrusor inhibition induced by stimulation of pudendal nerve afferents. Neurourol Urodyn, 1986. 5: 381.
https://pubmed.ncbi.nlm.nih.gov/4815623/
148.Gross, T., et al. Transcutaneous Electrical Nerve Stimulation for Treating Neurogenic Lower Urinary Tract Dysfunction: A Systematic Review. Eur Urol, 2016. 69: 1102.
https://pubmed.ncbi.nlm.nih.gov/26831506/
149.Vaughan, C.P., et al. Behavioral therapy for urinary symptoms in Parkinson’s disease: A randomized clinical trial. Neurourol Urodyn, 2019. 38: 1737.
https://pubmed.ncbi.nlm.nih.gov/31187552/
150.Rees, J., et al. Bladder training for urinary tract symptoms in Parkinson disease: A randomized controlled trial. Neurology, 2020. 94: E1427.
https://pubmed.ncbi.nlm.nih.gov/32054791/
151.Schneider, M.P., et al. Tibial Nerve Stimulation for Treating Neurogenic Lower Urinary Tract Dysfunction: A Systematic Review. Eur Urol, 2015.
https://pubmed.ncbi.nlm.nih.gov/26194043/
152.Booth, J., et al. The effectiveness of transcutaneous tibial nerve stimulation (TTNS) for adults with overactive bladder syndrome: A systematic review. Neurourol Urodyn, 2018. 37: 528.
https://pubmed.ncbi.nlm.nih.gov/28731583/
153.Stampas, A., et al. Feasibility of self-administered neuromodulation for neurogenic bladder in spinal cord injury. Int Neurourol J, 2019. 23: 249.
https://pubmed.ncbi.nlm.nih.gov/31607105/
154.Liu, Y., et al. Effects of Transcutaneous Electrical Nerve Stimulation at Two Frequencies on Urinary Incontinence in Poststroke Patients: A Randomized Controlled Trial. Am J Phys Med Rehabil, 2016. 95: 183.
https://pubmed.ncbi.nlm.nih.gov/26259053/
155.Guo, G.Y., et al. Effectiveness of neuromuscular electrical stimulation therapy in patients with urinary incontinence after stroke: A randomized sham controlled trial. Medicine, 2018. 97: e13702.
https://pubmed.ncbi.nlm.nih.gov/30593142/
156.Shen, S.X., et al. A retrospective study of neuromuscular electrical stimulation for treating women with post-stroke incontinence. Medicine (United States), 2018. 97: e11264.
https://pubmed.ncbi.nlm.nih.gov/29952999/
157.Araujo, T.G., et al. Transcutaneous tibial nerve home stimulation for overactive bladder in women with Parkinson’s disease: A randomized clinical trial. Neurourol Urodyn, 2021. 40: 538.
https://pubmed.ncbi.nlm.nih.gov/33326648/
158.Stampas, A., et al. Bladder neuromodulation in acute spinal cord injury via transcutaneous tibial nerve stimulation: Cystometrogram and autonomic nervous system evidence from a randomized control pilot trial. Front Neurosci, 2019. 13: 119.
https://pubmed.ncbi.nlm.nih.gov/30837835/
159.Stampas, A., et al. Safety, Feasibility, and Efficacy of Transcutaneous Tibial Nerve Stimulation in Acute Spinal Cord Injury Neurogenic Bladder: A Randomized Control Pilot Trial. Neuromodulation, 2019. 22: 716.
https://pubmed.ncbi.nlm.nih.gov/30284350/
160.Parittotokkaporn, S., et al. Non-invasive neuromodulation for bowel, bladder and sexual restoration following spinal cord injury: A systematic review. Clin Neurol Neurosurg, 2020. 194: 105822.
https://pubmed.ncbi.nlm.nih.gov/32334284/
161.Daia, C., et al. Interferential electrical stimulation for improved bladder management following spinal cord injury. Biomed Rep, 2019. 11: 115.
https://pubmed.ncbi.nlm.nih.gov/31423306/
162.McClurg, D., et al. Neuromuscular electrical stimulation and the treatment of lower urinary tract dysfunction in multiple sclerosis--a double blind, placebo controlled, randomised clinical trial. Neurourol Urodyn, 2008. 27: 231.
https://pubmed.ncbi.nlm.nih.gov/17705160/
163.Ferreira, A.P.S., et al. A Controlled Clinical Trial On The Effects Of Exercise On Lower Urinary Tract Symptoms In Women With Multiple Sclerosis. Am J Phys Med Rehabil, 2019.
https://pubmed.ncbi.nlm.nih.gov/30932917/
164.McClurg, D., et al. Comparison of pelvic floor muscle training, electromyography biofeedback, and neuromuscular electrical stimulation for bladder dysfunction in people with multiple sclerosis: a randomized pilot study. Neurourol Urodyn, 2006. 25: 337.
https://pubmed.ncbi.nlm.nih.gov/16637070/
165.Ferreira, A.P., et al. Impact of a Pelvic Floor Training Program Among Women with Multiple Sclerosis: A Controlled Clinical Trial. Am J Phys Med Rehabil, 2016. 95: 1.
https://pubmed.ncbi.nlm.nih.gov/25888662/
166.Elmelund, M., et al. The effect of pelvic floor muscle training and intravaginal electrical stimulation on urinary incontinence in women with incomplete spinal cord injury: an investigator-blinded parallel randomized clinical trial. Int Urogyn J, 2018. 29: 1597.
https://pubmed.ncbi.nlm.nih.gov/29574482/
167.Hagerty, J.A., et al. Intravesical electrotherapy for neurogenic bladder dysfunction: a 22-year experience. J Urol, 2007. 178: 1680.
https://pubmed.ncbi.nlm.nih.gov/17707024/
168.Primus, G., et al. Restoration of micturition in patients with acontractile and hypocontractile detrusor by transurethral electrical bladder stimulation. Neurourol Urodyn, 1996. 15: 489.
https://pubmed.ncbi.nlm.nih.gov/8857617/
169.Lombardi, G., et al. Clinical efficacy of intravesical electrostimulation on incomplete spinal cord patients suffering from chronic neurogenic non-obstructive retention: a 15-year single centre retrospective study. Spinal Cord, 2013. 51: 232.
https://pubmed.ncbi.nlm.nih.gov/23147136/
170.Nardone, R., et al. Transcranial magnetic stimulation and bladder function: A systematic review. Clin Neurophys, 2019. 130: 2032.
https://pubmed.ncbi.nlm.nih.gov/31541980/
171.El-Habashy, H., et al. The effect of cortical versus sacral repetitive magnetic stimulation on lower urinary tract dysfunction in patients with multiple sclerosis. Acta Neurol Belg, 2020. 120: 141.
https://pubmed.ncbi.nlm.nih.gov/31828602/
172.Thomas, L.H., et al. Treatment of urinary incontinence after stroke in adults. Cochrane Database Syst Rev, 2008: Cd004462.
https://pubmed.ncbi.nlm.nih.gov/18254050/
173.Yeo, L., et al. Urinary tract dysfunction in Parkinson’s disease: a review. Int Urol Nephrol, 2012. 44: 415.
https://pubmed.ncbi.nlm.nih.gov/21553114/
174.Phe, V., et al. Management of neurogenic bladder in patients with multiple sclerosis. Nat Rev Urol, 2016. 13: 275.
https://pubmed.ncbi.nlm.nih.gov/27030526/
175.Andersson, K.E. Antimuscarinic mechanisms and the overactive detrusor: an update. Eur Urol, 2011. 59: 377.
https://pubmed.ncbi.nlm.nih.gov/21168951/
176.Bennett, N., et al. Can higher doses of oxybutynin improve efficacy in neurogenic bladder? J Urol, 2004. 171: 749.
https://pubmed.ncbi.nlm.nih.gov/14713802/
177.Horstmann, M., et al. Neurogenic bladder treatment by doubling the recommended antimuscarinic dosage. Neurourol Urodyn, 2006. 25: 441.
https://pubmed.ncbi.nlm.nih.gov/16847942/
178.Kennelly, M.J., et al. Overactive bladder: pharmacologic treatments in the neurogenic population. Rev Urol, 2008. 10: 182.
https://pubmed.ncbi.nlm.nih.gov/18836537/
179.Madersbacher, H., et al. Neurogenic detrusor overactivity in adults: a review on efficacy, tolerability and safety of oral antimuscarinics. Spinal Cord, 2013. 51: 432.
https://pubmed.ncbi.nlm.nih.gov/23743498/
180.Madhuvrata, P., et al. Anticholinergic drugs for adult neurogenic detrusor overactivity: a systematic review and meta-analysis. Eur Urol, 2012. 62: 816.
https://pubmed.ncbi.nlm.nih.gov/22397851/
181.Stohrer, M., et al. EAU guidelines on neurogenic lower urinary tract dysfunction. Eur Urol, 2009. 56: 81.
https://pubmed.ncbi.nlm.nih.gov/19403235/
182.Mehnert, U., et al. The management of urinary incontinence in the male neurological patient. Curr Opin Urol, 2014. 24: 586.
https://pubmed.ncbi.nlm.nih.gov/25389549/
183.Stothers, L., et al. An integrative review of standardized clinical evaluation tool utilization in anticholinergic drug trials for neurogenic lower urinary tract dysfunction. Spinal Cord, 2016. 31: 31.
https://pubmed.ncbi.nlm.nih.gov/27241452/
184.Amend, B., et al. Effective treatment of neurogenic detrusor dysfunction by combined high-dosed antimuscarinics without increased side-effects. Eur Urol, 2008. 53: 1021.
https://pubmed.ncbi.nlm.nih.gov/18243516/
185.Cameron, A.P. Pharmacologic therapy for the neurogenic bladder. Urol Clin North Am, 2010. 37: 495.
https://pubmed.ncbi.nlm.nih.gov/20955901/
186.Menarini, M., et al. Trospium chloride in patients with neurogenic detrusor overactivity: is dose titration of benefit to the patients? Int J Clin Pharmacol Ther, 2006. 44: 623.
https://pubmed.ncbi.nlm.nih.gov/17190372/
187.Nardulli, R., et al. Combined antimuscarinics for treatment of neurogenic overactive bladder. Int
J Immunopathol Pharmacol, 2012. 25: 35s.
https://pubmed.ncbi.nlm.nih.gov/22652160/
188.Tijnagel, M.J., et al. Real life persistence rate with antimuscarinic treatment in patients with idiopathic or neurogenic overactive bladder: a prospective cohort study with solifenacin. BMC Urol, 2017. 17: 13.
https://pubmed.ncbi.nlm.nih.gov/28403849/
189.Cameron, A.P., et al. Combination drug therapy improves compliance of the neurogenic bladder.
J Urol, 2009. 182: 1062.
https://pubmed.ncbi.nlm.nih.gov/19616807/
190.Isik, A.T., et al. Trospium and cognition in patients with late onset Alzheimer disease. J Nutr Health Aging, 2009. 13: 672.
https://pubmed.ncbi.nlm.nih.gov/19657549/
191.Ethans, K.D., et al. Efficacy and safety of tolterodine in people with neurogenic detrusor overactivity. J Spinal Cord Med, 2004. 27: 214.
https://pubmed.ncbi.nlm.nih.gov/15478523/
192.McKeage, K. Propiverine: A review of its use in the treatment of adults and children with overactive bladder associated with idiopathic or neurogenic detrusor overactivity, and in men with lower urinary tract symptoms. Clin Drug Invest, 2013. 33: 71.
https://pubmed.ncbi.nlm.nih.gov/23288694/
193.Nicholas, R.S., et al. Anticholinergics for urinary symptoms in multiple sclerosis. Cochrane Database Syst Rev, 2009: Cd004193.
https://pubmed.ncbi.nlm.nih.gov/19160231/
194.van Rey, F., et al. Solifenacin in multiple sclerosis patients with overactive bladder: a prospective study. Adv Urol, 2011. 2011: 834753.
https://pubmed.ncbi.nlm.nih.gov/21687581/
195.Bycroft, J., et al. The effect of darifenacin on neurogenic detrusor overactivity in patients with spinal cord injury. Neurourol Urodyn 2003. 22: A190.
https://www.ics.org/Abstracts/Publish/41/000190.pdf
196.Carl, S., et al. Darifenacin is also effective in neurogenic bladder dysfunction (multiple sclerosis). Urology, 2006. 68 250.
https://www.goldjournal.net/article/S0090-4295(06)01724-9/fulltext
197.Amarenco, G., et al. Solifenacin is effective and well tolerated in patients with neurogenic detrusor overactivity: Results from the double-blind, randomized, active- and placebo-controlled SONIC urodynamic study. Neurourol Urodyn, 2015. 29: 29.
https://pubmed.ncbi.nlm.nih.gov/26714009/
198.Zesiewicz, T.A., et al. Randomized, controlled pilot trial of solifenacin succinate for overactive bladder in Parkinson’s disease. Parkinsonism Relat Disord, 2015. 21: 514.
https://pubmed.ncbi.nlm.nih.gov/25814050/
199.Kaga, K., et al. Urodynamic efficacy of fesoterodine for the treatment of neurogenic detrusor overactivity and/or low compliance bladder. Int J Urol, 2020. 27: 899.
https://pubmed.ncbi.nlm.nih.gov/32767525/
200.Yonguc, T., et al. Randomized, controlled trial of fesoterodine fumarate for overactive bladder in Parkinson’s disease. World J Urol, 2020. 38: 2013.
https://pubmed.ncbi.nlm.nih.gov/31642953/
201.Sakakibara, R., et al. Imidafenacin on bladder and cognitive function in neurologic OAB patients. Clin Autonom Res, 2013. 23: 189.
https://pubmed.ncbi.nlm.nih.gov/23820664/
202.Sugiyama, H., et al. Effect of imidafenacin on the urodynamic parameters of patients with indwelling bladder catheters due to spinal cord injury. Spinal Cord, 2017. 55: 187.
https://pubmed.ncbi.nlm.nih.gov/27897185/
203.Stohrer, M., et al. Efficacy and tolerability of propiverine hydrochloride extended-release compared with immediate-release in patients with neurogenic detrusor overactivity. Spinal Cord, 2013. 51: 419.
https://pubmed.ncbi.nlm.nih.gov/23338657/
204.Schroder, A., et al. Efficacy, safety, and tolerability of intravesically administered 0.1% oxybutynin hydrochloride solution in adult patients with neurogenic bladder: A randomized, prospective, controlled multi-center trial. Neurourol Urodyn, 2016. 35: 582.
https://pubmed.ncbi.nlm.nih.gov/25754454/
205.Dmochowski, R.R., et al. Increased risk of incident dementia following use of anticholinergic agents: A systematic literature review and meta-analysis. Neurourol Urodyn, 2021. 40: 28.
https://pubmed.ncbi.nlm.nih.gov/33098213/
206.El Helou, E., et al. The use of mirabegron in neurogenic bladder: a systematic review. World J Urol, 2020. 38: 2435.
https://pubmed.ncbi.nlm.nih.gov/31802206/
207.Glykas, I., et al. B3 agonists or anticholinergics in the treatment of the lower urinary tract dysfunction in patients with multiple sclerosis?-A randomized study. World J Urol, 2021.
https://pubmed.ncbi.nlm.nih.gov/33386947/
208.Krhut, J., et al. Efficacy and safety of mirabegron for the treatment of neurogenic detrusor overactivity-Prospective, randomized, double-blind, placebo-controlled study. Neurourol Urodyns, 2018. 37: 2226.
https://pubmed.ncbi.nlm.nih.gov/29603781
209.Welk, B., et al. A pilot randomized-controlled trial of the urodynamic efficacy of mirabegron for patients with neurogenic lower urinary tract dysfunction. Neurourol Urodyn, 2018. 37: 2810.
https://pubmed.ncbi.nlm.nih.gov/30168626/
210.Chen, S.F., et al. Therapeutic efficacy of low-dose (25mg) mirabegron therapy for patients with mild to moderate overactive bladder symptoms due to central nervous system diseases. Low Urin Tract Sympt, 2018. 11: O53.
https://pubmed.ncbi.nlm.nih.gov/29380517/
211.Peyronnet, B., et al. Mirabegron in patients with Parkinson disease and overactive bladder symptoms: A retrospective cohort. Parkinsonism Relat Disord, 2018. 57: 22.
https://pubmed.ncbi.nlm.nih.gov/30037689/
212.Cho, S.Y., et al. Mirabegron for treatment of overactive bladder symptoms in patients with Parkinson’s disease: A double-blind, randomized placebo-controlled trial (Parkinson’s Disease Overactive bladder Mirabegron, PaDoMi Study). Neurourol Urodyn, 2021. 40: 286.
https://pubmed.ncbi.nlm.nih.gov/33389776/
213.Zachariou, A., et al. Effective treatment of neurogenic detrusor overactivity in multiple sclerosis patients using desmopressin and mirabegron. Can J Urol, 2017. 24: 9107.
https://pubmed.ncbi.nlm.nih.gov/29260636/
214.Abo Youssef, N., et al. Cannabinoids for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: a systematic review and meta-analysis. BJU Int, 2017. 119: 515.
https://pubmed.ncbi.nlm.nih.gov/28058780/
215.Francomano, D., et al. Effects of daily tadalafil on lower urinary tract symptoms in young men with multiple sclerosis and erectile dysfunction: a pilot study. J Endocrinol Invest, 2017. 40: 275.
https://pubmed.ncbi.nlm.nih.gov/27752863/
216.Phe, V., et al. Desmopressin for treating nocturia in patients with multiple sclerosis: A systematic review: A report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS). Neurourol Urodyn, 2019. 38: 563.
https://pubmed.ncbi.nlm.nih.gov/30653737/
217.Barendrecht, M.M., et al. Is the use of parasympathomimetics for treating an underactive urinary bladder evidence-based? BJU Int, 2007. 99: 749.
https://pubmed.ncbi.nlm.nih.gov/17233798/
218.Apostolidis, A. Taming the cannabinoids: new potential in the pharmacologic control of lower urinary tract dysfunction. Eur Urol, 2012. 61: 107.
https://pubmed.ncbi.nlm.nih.gov/21996529/
219.Gratzke, C., et al. Effects of cannabinor, a novel selective cannabinoid 2 receptor agonist, on bladder function in normal rats. Eur Urol, 2010. 57: 1093.
https://pubmed.ncbi.nlm.nih.gov/20207474/
220.Abrams, P., et al. Tamsulosin: efficacy and safety in patients with neurogenic lower urinary tract dysfunction due to suprasacral spinal cord injury. J Urol, 2003. 170: 1242.
https://pubmed.ncbi.nlm.nih.gov/14501734/
221.Gomes, C.M., et al. Neurological status predicts response to alpha-blockers in men with voiding dysfunction and Parkinson’s disease. Clinics, 2014. 69: 817.
https://pubmed.ncbi.nlm.nih.gov/25627993/
222.Moon, K.H., et al. A 12-week, open label, multi-center study to evaluate the clinical efficacy and safety of silodosin on voiding dysfunction in patients with neurogenic bladder. Low Urin Tract Sympt, 2015. 7: 27.
https://pubmed.ncbi.nlm.nih.gov/26663648/
223.Tornic, J., et al. Alpha-blockers for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: A systematic review and meta-analysis. A report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS). Neurourol Urodyn, 2019.
38: 1482.
https://pubmed.ncbi.nlm.nih.gov/31099113/
224.Sung, H.H., et al. Efficacy and safety of naftopidil in patients with neurogenic lower urinary tract dysfunction: An 8-week, active-controlled, stratified-randomized, double-blind, double-dummy, parallel group, noninferiority, multicenter design. Int Neurourol J, 2020. 24: 163.
https://pubmed.ncbi.nlm.nih.gov/32615679/
225.Guttmann, L., et al. The value of intermittent catheterisation in the early management of traumatic paraplegia and tetraplegia. Paraplegia, 1966. 4: 63.
https://pubmed.ncbi.nlm.nih.gov/5969402/
226.Lapides, J., et al. Clean, intermittent self-catheterization in the treatment of urinary tract disease.
J Urol, 1972. 107: 458.
https://pubmed.ncbi.nlm.nih.gov/5010715/
227.Elliott, C.S., et al. Validation of Upper Extremity Motor Function as a Key Predictor of Bladder Management After Spinal Cord Injury. Arch Phys Med Rehabil, 2019. 100: 1939.
https://pubmed.ncbi.nlm.nih.gov/31348899/
228.Wyndaele, J.J. Intermittent catheterization: which is the optimal technique? Spinal Cord, 2002. 40: 432.
https://pubmed.ncbi.nlm.nih.gov/12185603/
229.Prieto-Fingerhut, T., et al. A study comparing sterile and nonsterile urethral catheterization in patients with spinal cord injury. Rehabil Nurs, 1997. 22: 299.
https://pubmed.ncbi.nlm.nih.gov/9416190/
230.Jamison, J., et al. Catheter policies for management of long term voiding problems in adults with neurogenic bladder disorders. Cochrane Database Syst Rev, 2013. 11: CD004375.
https://pubmed.ncbi.nlm.nih.gov/24249436/
231.Corona, L.E., et al. Intermittent catheterization and urinary tract infection in multiple sclerosis patients. Can J Urol, 2020. 27: 10294.
https://pubmed.ncbi.nlm.nih.gov/32861254/
232.Crescenze, I.M., et al. Predictors of low urinary quality of life in spinal cord injury patients on clean intermittent catheterization. Neurourol Urodyn, 2019. 38: 1332.
https://pubmed.ncbi.nlm.nih.gov/30912199/233.
233.Patel, D.P., et al. Reasons for cessation of clean intermittent catheterization after spinal cord injury: Results from the Neurogenic Bladder Research Group spinal cord injury registry. Neurourology and Urodynamics, 2020. 39: 211.
https://pubmed.ncbi.nlm.nih.gov/31578784/
234.Goetz, L.L., et al. International Spinal Cord Injury Urinary Tract Infection Basic Data Set. Spinal Cord, 2013. 51: 700.
https://pubmed.ncbi.nlm.nih.gov/23896666/
235.Bakke, A., et al. Physical predictors of infection in patients treated with clean intermittent catheterization: a prospective 7-year study. Br J Urol, 1997. 79: 85.
https://pubmed.ncbi.nlm.nih.gov/9043503/
236.Günther, M., et al. Auswirkungen des aseptischen intermittierenden Katheterismus auf die männliche Harnröhre. Der Urologe B, 2001. 41: 359.
https://link.springer.com/article/10.1007/s001310170044
237.Kurze, I., et al. Intermittent Catheterisation and Prevention of Urinary Tract Infections in Patients with Neurogenic Lower Urinary Tract Dysfunction - Best PracticeAn Overview. [German]. Aktuelle Neurol, 2015. 42: 515. [No abstract available].
238.Waller, L., et al. Clean intermittent catheterization in spinal cord injury patients: long-term followup of a hydrophilic low friction technique. J Urol, 1995. 153: 345.
https://pubmed.ncbi.nlm.nih.gov/7815579/
239.Wyndaele, J.J. Complications of intermittent catheterization: their prevention and treatment. Spinal Cord, 2002. 40: 536.
https://pubmed.ncbi.nlm.nih.gov/12235537/
240.Woodbury, M.G., et al. Intermittent catheterization practices following spinal cord injury: a national survey. Can J Urol, 2008. 15: 4065.
https://pubmed.ncbi.nlm.nih.gov/18570710/
241.Bennett, C.J., et al. Comparison of bladder management complication outcomes in female spinal cord injury patients. J Urol, 1995. 153: 1458.
https://pubmed.ncbi.nlm.nih.gov/7714965/
242.Chao, R., et al. Fate of upper urinary tracts in patients with indwelling catheters after spinal cord injury. Urology, 1993. 42: 259.
https://pubmed.ncbi.nlm.nih.gov/8379025/
243.Larsen, L.D., et al. Retrospective analysis of urologic complications in male patients with spinal cord injury managed with and without indwelling urinary catheters. Urology, 1997. 50: 4
https://pubmed.ncbi.nlm.nih.gov/9301708/
244.Mitsui, T., et al. Is suprapubic cystostomy an optimal urinary management in high quadriplegics?. A comparative study of suprapubic cystostomy and clean intermittent catheterization. Eur Urol, 2000. 38: 434.
https://pubmed.ncbi.nlm.nih.gov/11025382/
245.Weld, K.J., et al. Effect of bladder management on urological complications in spinal cord injured patients. J Urol, 2000. 163: 768.
https://pubmed.ncbi.nlm.nih.gov/10687973/
246.Weld, K.J., et al. Influences on renal function in chronic spinal cord injured patients. J Urol, 2000. 164: 1490.
https://pubmed.ncbi.nlm.nih.gov/11025689/
247.West, D.A., et al. Role of chronic catheterization in the development of bladder cancer in patients with spinal cord injury. Urology, 1999. 53: 292.
https://pubmed.ncbi.nlm.nih.gov/9933042/
248.Lavelle, R.S., et al. Quality of life after suprapubic catheter placement in patients with neurogenic bladder conditions. Neurourol Urodyn, 2016. 35: 831.
https://pubmed.ncbi.nlm.nih.gov/26197729/
249.Hollingsworth, J.M., et al. Determining the noninfectious complications of indwelling urethral catheters: a systematic review and meta-analysis. Ann Intern Med, 2013. 159: 401.
https://pubmed.ncbi.nlm.nih.gov/24042368/
250.Buyse, G., et al. Intravesical oxybutynin for neurogenic bladder dysfunction: less systemic side effects due to reduced first pass metabolism. J Urol, 1998. 160: 892.
https://pubmed.ncbi.nlm.nih.gov/9720583/
251.Di Stasi, S.M., et al. Intravesical oxybutynin: mode of action assessed by passive diffusion and electromotive administration with pharmacokinetics of oxybutynin and N-desethyl oxybutynin.
J Urol, 2001. 166: 2232.
https://pubmed.ncbi.nlm.nih.gov/11696741/
252.Haferkamp, A., et al. Dosage escalation of intravesical oxybutynin in the treatment of neurogenic bladder patients. Spinal Cord, 2000. 38: 250.
https://pubmed.ncbi.nlm.nih.gov/10822396/
253.Pannek, J., et al. Combined intravesical and oral oxybutynin chloride in adult patients with spinal cord injury. Urology, 2000. 55: 358.
https://pubmed.ncbi.nlm.nih.gov/10699610/
254.Giannantoni, A., et al. Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study. J Urol, 2004. 172: 240.
https://pubmed.ncbi.nlm.nih.gov/15201783/
255.Kim, J.H., et al. Intravesical resiniferatoxin for refractory detrusor hyperreflexia: a multicenter, blinded, randomized, placebo-controlled trial. J Spinal Cord Med, 2003. 26: 358.
https://pubmed.ncbi.nlm.nih.gov/14992337/
256.Phe, V., et al. Intravesical vanilloids for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: A systematic review and meta-analysis. A report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS). Neurourol Urodyn, 2018. 37: 67.
https://pubmed.ncbi.nlm.nih.gov/28618110/
257.Del Popolo, G., et al. Neurogenic detrusor overactivity treated with english botulinum toxin a: 8-year experience of one single centre. Eur Urol, 2008. 53: 1013.
https://pubmed.ncbi.nlm.nih.gov/17950989/
258.Reitz, A., et al. European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol, 2004. 45: 510.
https://pubmed.ncbi.nlm.nih.gov/15041117/
259.Yuan, H., et al. Efficacy and Adverse Events Associated With Use of OnabotulinumtoxinA for Treatment of Neurogenic Detrusor Overactivity: A Meta-Analysis. Int Neurourol J, 2017. 21:53.
https://pubmed.ncbi.nlm.nih.gov/28361515/
260.Cheng, T., et al. Efficacy and Safety of OnabotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. PLoS One, 2016. 11: e0159307.
https://pubmed.ncbi.nlm.nih.gov/27463810/
261.Wagle Shukla, A., et al. Botulinum Toxin Therapy for Parkinson’s Disease. Semin Neurol, 2017. 37:193.
https://pubmed.ncbi.nlm.nih.gov/28511260/
262.Wu, S.-J., et al. Clinical outcomes of botulinum toxin A management for neurogenic detrusor overactivity: meta-analysis. Renal Failure, 2019. 41: 937.
https://pubmed.ncbi.nlm.nih.gov/31599184/
263.Koschorke, M., et al. Intradetrusor onabotulinumtoxinA injections for refractory neurogenic detrusor overactivity incontinence: do we need urodynamic investigation for outcome assessment? BJU Int, 2017. 120: 848.
https://pubmed.ncbi.nlm.nih.gov/28771936/
264.Ginsberg, D., et al. Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity. J Urol, 2012. 187: 2131.
https://pubmed.ncbi.nlm.nih.gov/22503020/
265.Grosse, J., et al. Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrusor overactivity and incontinence. Eur Urol, 2005. 47: 653.
https://pubmed.ncbi.nlm.nih.gov/15826758/
266.Rovner, E., et al. Long-Term Efficacy and Safety of OnabotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity Who Completed 4 Years of Treatment. J Urol., 2016.
https://pubmed.ncbi.nlm.nih.gov/27091236/
267.Ni, J., et al. Is repeat Botulinum Toxin A injection valuable for neurogenic detrusor overactivity-A systematic review and meta-analysis. Neurourol Urodyn, 2018. 37: 542.
https://pubmed.ncbi.nlm.nih.gov/28745818/
268.Michel, F., et al. Botulinum toxin type A injection after failure of augmentation enterocystoplasty performed for neurogenic detrusor overactivity: preliminary results of a salvage strategy. The ENTEROTOX study. Urology, 2019.
https://pubmed.ncbi.nlm.nih.gov/30926380/
269.Toia, B., et al. The efficacy of onabotulinumtoxinA in patients with previous failed augmentation cystoplasty: Cohort series and literature review. Neurourol Urodyn, 2020. 39: 1831.
https://pubmed.ncbi.nlm.nih.gov/32572987/
270.Bottet, F., et al. Switch to Abobotulinum toxin A may be useful in the treatment of neurogenic detrusor overactivity when intradetrusor injections of Onabotulinum toxin A failed. Neurourol Urodyn, 2017. 21: 21.
https://pubmed.ncbi.nlm.nih.gov/28431196/
271.Leu, R., et al. Complications of Botox and their Management. Curr Urol Rep, 2018. 19: 90.
https://pubmed.ncbi.nlm.nih.gov/30194497/
272.Tullman, M., et al. Low-dose onabotulinumtoxinA improves urinary symptoms in noncatheterizing patients with MS. Neurology, 2018. 91: e657.
https://pubmed.ncbi.nlm.nih.gov/30030330/
273.Tyagi, P., et al. Past, Present and Future of Chemodenervation with Botulinum Toxin in the Treatment of Overactive Bladder. J Urol, 2017. 197: 982.
https://pubmed.ncbi.nlm.nih.gov/27871929/
274.Young, M.J., et al. Another Therapeutic Role for Intravesical Botulinum Toxin: Patients with Long-stay Catheters and Refractory Bladder Pain and Catheter Bypass Leakage. Eur Urol Focus, 2018.
https://pubmed.ncbi.nlm.nih.gov/30392867/
275.Dykstra, D.D., et al. Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double-blind study. Arch Phys Med Rehabil, 1990. 71: 24.
https://pubmed.ncbi.nlm.nih.gov/2297305/
276.Schurch, B., et al. Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia: a prospective study in 24 spinal cord injury patients. J Urol, 1996. 155: 1023.
https://pubmed.ncbi.nlm.nih.gov/8583552/
277.Huang, M., et al. Effects of botulinum toxin A injections in spinal cord injury patients with detrusor overactivity and detrusor sphincter dyssynergia. J Rehabil Med, 2016. 48: 683.
https://pubmed.ncbi.nlm.nih.gov/27563834/
278.Utomo, E., et al. Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction. Cochrane Database Syst Rev, 2014. 5: Cd004927.
https://pubmed.ncbi.nlm.nih.gov/24859260/
279.Chancellor, M.B., et al. Prospective comparison of external sphincter balloon dilatation and prosthesis placement with external sphincterotomy in spinal cord injured men. Arch Phys Med Rehabil, 1994. 75: 297.
https://pubmed.ncbi.nlm.nih.gov/8129583/
280.Bennett, J.K., et al. Collagen injections for intrinsic sphincter deficiency in the neuropathic urethra. Paraplegia, 1995. 33: 697.
https://pubmed.ncbi.nlm.nih.gov/8927407/
281.Block, C.A., et al. Long-term efficacy of periurethral collagen injection for the treatment of urinary incontinence secondary to myelomeningocele. J Urol, 2003. 169: 327.
https://pubmed.ncbi.nlm.nih.gov/12478183/
282.Schurch, B., et al. Intraurethral sphincter prosthesis to treat hyporeflexic bladders in women: does it work? BJU Int, 1999. 84: 789.
https://pubmed.ncbi.nlm.nih.gov/10532973/
283.Reuvers, S.H.M., et al. Heterogeneity in reporting on urinary outcome and cure after surgical interventions for stress urinary incontinence in adult neuro-urological patients: A systematic review. Neurourol Urodyn, 2018. 37: 554.
https://pubmed.ncbi.nlm.nih.gov/28792081/
284.Barthold, J.S., et al. Results of the rectus fascial sling and wrap procedures for the treatment of neurogenic sphincteric incontinence. J Urol, 1999. 161: 272.
https://pubmed.ncbi.nlm.nih.gov/10037423/
285.Gormley, E.A., et al. Pubovaginal slings for the management of urinary incontinence in female adolescents. J Urol, 1994. 152: 822.
https://pubmed.ncbi.nlm.nih.gov/8022024/
286.Kakizaki, H., et al. Fascial sling for the management of urinary incontinence due to sphincter incompetence. J Urol, 1995. 153: 644.
https://pubmed.ncbi.nlm.nih.gov/7861504/
287.Mingin, G.C., et al. The rectus myofascial wrap in the management of urethral sphincter incompetence. BJU Int, 2002. 90: 550.
https://pubmed.ncbi.nlm.nih.gov/12230615/
288.Abdul-Rahman, A., et al. Long-term outcome of tension-free vaginal tape for treating stress incontinence in women with neuropathic bladders. BJU Int, 2010. 106: 827.
https://pubmed.ncbi.nlm.nih.gov/20132201/
289.Losco, G.S., et al. Long-term outcome of transobturator tape (TOT) for treatment of stress urinary incontinence in females with neuropathic bladders. Spinal Cord, 2015. 53: 544.
https://pubmed.ncbi.nlm.nih.gov/25917951/
290.El-Azab, A.S., et al. Midurethral slings versus the standard pubovaginal slings for women with neurogenic stress urinary incontinence. Int Urogynecol J, 2015. 26: 427.
https://pubmed.ncbi.nlm.nih.gov/25315169/
291.Musco, S., et al. Efficacy and Safety of Surgical Treatments for Neurogenic Stress Urinary Incontinence in Adults: A Systematic Review. Eur Urol Focus, 2021.
https://pubmed.ncbi.nlm.nih.gov/34509413/
292.Athanasopoulos, A., et al. Treating stress urinary incontinence in female patients with neuropathic bladder: the value of the autologous fascia rectus sling. Int Urol Nephrol, 2012. 44: 1363.
https://pubmed.ncbi.nlm.nih.gov/22821050/
293.Groen, L.A., et al. The AdVance male sling as a minimally invasive treatment for intrinsic sphincter deficiency in patients with neurogenic bladder sphincter dysfunction: a pilot study. Neurourol Urodyn, 2012. 31: 1284.
https://pubmed.ncbi.nlm.nih.gov/22847896/
294.Mehnert, U., et al. Treatment of neurogenic stress urinary incontinence using an adjustable continence device: 4-year followup. J Urol, 2012. 188: 2274.
https://pubmed.ncbi.nlm.nih.gov/23083648/
295.Daneshmand, S., et al. Puboprostatic sling repair for treatment of urethral incompetence in adult neurogenic incontinence. J Urol, 2003. 169: 199.
https://pubmed.ncbi.nlm.nih.gov/12478135/
296.Herschorn, S., et al. Fascial slings and bladder neck tapering in the treatment of male neurogenic incontinence. J Urol, 1992. 147: 1073.
https://pubmed.ncbi.nlm.nih.gov/1552586/
297.Light, J.K., et al. Use of the artificial urinary sphincter in spinal cord injury patients. J Urol, 1983. 130: 1127.
https://pubmed.ncbi.nlm.nih.gov/6644893/
298.Farag, F., et al. Surgical treatment of neurogenic stress urinary incontinence: A systematic review of quality assessment and surgical outcomes. Neurourol Urodyn, 2016. 35: 21.
https://pubmed.ncbi.nlm.nih.gov/25327633/
299.Kim, S.P., et al. Long-term durability and functional outcomes among patients with artificial urinary sphincters: a 10-year retrospective review from the University of Michigan. J Urol, 2008. 179: 1912.
https://pubmed.ncbi.nlm.nih.gov/18353376/
300.Wang, R., et al. Long-term outcomes after primary failures of artificial urinary sphincter implantation. Urology, 2012. 79: 922.
https://pubmed.ncbi.nlm.nih.gov/22305763/
301.Guillot-Tantay, C., et al. [Male neurogenic stress urinary incontinence treated by artificial urinary sphincter AMS 800TM (Boston Scientific, Boston, USA): Very long-term results (>25 years)]. Progres Urol, 2018. 28: 39.
https://pubmed.ncbi.nlm.nih.gov/29102375/
302.Fournier, G., et al. Robotic-assisted laparoscopic implantation of artificial urinary sphincter in women with intrinsic sphincter deficiency incontinence: initial results. Urology, 2014. 84: 1094.
https://pubmed.ncbi.nlm.nih.gov/25443911/
303.Biardeau, X., et al. Robot-assisted laparoscopic approach for artificial urinary sphincter implantation in 11 women with urinary stress incontinence: surgical technique and initial experience. Eur Urol, 2015. 67: 937.
https://pubmed.ncbi.nlm.nih.gov/25582931/
304.Peyronnet, B., et al. Artificial urinary sphincter implantation in women with stress urinary incontinence: preliminary comparison of robot-assisted and open approaches. Int Urogynecol J, 2016. 27: 475.
https://pubmed.ncbi.nlm.nih.gov/26431841/
305.Phe, V., et al. Stress urinary incontinence in female neurological patients: long-term functional outcomes after artificial urinary sphincter (AMS 800(TM) ) implantation. Neurourol Urodyn, 2017. 36: 764.
https://pubmed.ncbi.nlm.nih.gov/27080729/
306.Scott, K.A., et al. Use of Artificial Urinary Sphincter and Slings to Manage Neurogenic Bladder Following Spinal Cord Injury-Is It Safe? Curr Bladder Dysf Rep, 2017. 12: 311.
https://www.researchgate.net/publication/319366606
307.Tricard, T., et al. Outcomes of artificial urinary sphincter in female with neurological stress urinary incontinence: a long-term follow-up. World J Urol, 2021. 39: 157.
https://pubmed.ncbi.nlm.nih.gov/32052128/
308.Gasmi, A., et al. Long-term outcomes of artificial urinary sphincter in female patients with spina bifida. Neurourol Urodyn, 2021. 40: 412.
https://pubmed.ncbi.nlm.nih.gov/33197064/
309.Ammirati, E., et al. Management of male and female neurogenic stress urinary incontinence in spinal cord injured (SCI) patients using adjustable continence therapy. Urologia, 2017. 0: 16.
https://pubmed.ncbi.nlm.nih.gov/28525663/
310.Ronzi, Y., et al. Neurogenic stress urinary incontinence: is there a place for Adjustable Continence Therapy (ACTTM and ProACTTM, Uromedica, Plymouth, MN, USA)? A retrospective multicenter study. Spinal Cord, 2019.
https://pubmed.ncbi.nlm.nih.gov/30626977/
311.Janknegt, R.A., et al. Electrically stimulated gracilis sphincter for treatment of bladder sphincter incontinence. Lancet, 1992. 340: 1129.
https://pubmed.ncbi.nlm.nih.gov/1359213/
312.Chancellor, M.B., et al. Gracilis muscle transposition with electrical stimulation for sphincteric incontinence: a new approach. World J Urol, 1997. 15: 320.
https://pubmed.ncbi.nlm.nih.gov/9372585/
313.Chancellor, M.B., et al. Gracilis urethromyoplasty--an autologous urinary sphincter for neurologically impaired patients with stress incontinence. Spinal Cord, 1997. 35: 546.
https://pubmed.ncbi.nlm.nih.gov/9267922/
314.Donnahoo, K.K., et al. The Young-Dees-Leadbetter bladder neck repair for neurogenic incontinence. J Urol, 1999. 161: 1946.
https://pubmed.ncbi.nlm.nih.gov/10332478/
315.Kropp, K.A., et al. Urethral lengthening and reimplantation for neurogenic incontinence in children.
J Urol, 1986. 135: 533.
https://pubmed.ncbi.nlm.nih.gov/3944902/
316.Salle, J.L., et al. Urethral lengthening with anterior bladder wall flap (Pippi Salle procedure): modifications and extended indications of the technique. J Urol, 1997. 158: 585.
https://pubmed.ncbi.nlm.nih.gov/9224369/
317.Rawashdeh, Y.F., et al. International Children’s Continence Society’s recommendations for therapeutic intervention in congenital neuropathic bladder and bowel dysfunction in children. Neurourol Urodyn, 2012. 31: 615.
https://pubmed.ncbi.nlm.nih.gov/22532368/
318.Wyndaele, J.-J., et al. Surgical management of the neurogenic bladder after spinal cord injury. World J Urol, 2018. 26:1569.
https://pubmed.ncbi.nlm.nih.gov/29680953/
319.Moisey, C.U., et al. Results of transurethral resection of prostate in patients with cerebrovascular disease. Br J Urol, 1978. 50: 539.
https://pubmed.ncbi.nlm.nih.gov/88982/
320.Roth, B., et al. Benign prostatic obstruction and parkinson’s disease--should transurethral resection of the prostate be avoided? J Urol, 2009. 181: 2209.
https://pubmed.ncbi.nlm.nih.gov/19296974/
321.Elsaesser, E., et al. Urological operations for improvement of bladder voiding in paraplegic patients. Paraplegia, 1972. 10: 68.
https://pubmed.ncbi.nlm.nih.gov/5039331/
322.Cornejo-Davila, V., et al. Incidence of Urethral Stricture in Patients With Spinal Cord Injury Treated With Clean Intermittent Self-Catheterization. Urology, 2017. 99: 260.
https://pubmed.ncbi.nlm.nih.gov/27566143/
323.Perkash, I. Ablation of urethral strictures using contact chisel crystal firing neodymium:YAG laser.
J Urol, 1997. 157: 809.
https://pubmed.ncbi.nlm.nih.gov/9072572/
324.Schurch, B., et al. Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J Urol, 2005. 174: 196.
https://pubmed.ncbi.nlm.nih.gov/15947626/
325.Madersbacher, H., et al. Twelve o’clock sphincterotomy: technique, indications, results. (Abbreviated report). Urol Int, 1975. 30: 75.
https://pubmed.ncbi.nlm.nih.gov/1118951/
326.Perkash, I. Laser sphincterotomy and ablation of the prostate using a sapphire chisel contact tip firing neodymium:YAG laser. J Urol, 1994. 152: 2020.
https://pubmed.ncbi.nlm.nih.gov/7966667/
327.Noll, F., et al. Transurethral sphincterotomy in quadriplegic patients: long-term-follow-up. Neurourol Urodyn, 1995. 14: 351.
https://pubmed.ncbi.nlm.nih.gov/7581471/
328.Derry, F., et al. Audit of bladder neck resection in spinal cord injured patients. Spinal Cord, 1998.
36: 345.
https://pubmed.ncbi.nlm.nih.gov/9601115/
329.Perkash, I. Use of contact laser crystal tip firing Nd:YAG to relieve urinary outflow obstruction in male neurogenic bladder patients. J Clin Laser Med Surg, 1998. 16: 33.
https://pubmed.ncbi.nlm.nih.gov/9728128/
330.Chancellor, M.B., et al. Long-term followup of the North American multicenter UroLume trial for the treatment of external detrusor-sphincter dyssynergia. J Urol, 1999. 161: 1545.
https://pubmed.ncbi.nlm.nih.gov/10210393/
331.Seoane-Rodriguez, S., et al. Long-term follow-up study of intraurethral stents in spinal cord injured patients with detrusor-sphincter dyssynergia. Spinal Cord, 2007. 45: 621.
https://pubmed.ncbi.nlm.nih.gov/17211463/
332.Gajewski, J.B., et al. Removal of UroLume endoprosthesis: experience of the North American Study Group for detrusor-sphincter dyssynergia application. J Urol, 2000. 163: 773.
https://pubmed.ncbi.nlm.nih.gov/10687974/
333.Wilson, T.S., et al. UroLume stents: lessons learned. J Urol, 2002. 167: 2477.
https://pubmed.ncbi.nlm.nih.gov/11992061/
334.Abdul-Rahman, A., et al. A 20-year follow-up of the mesh wallstent in the treatment of detrusor external sphincter dyssynergia in patients with spinal cord injury. BJU Int, 2010. 106: 1510.
https://pubmed.ncbi.nlm.nih.gov/20500511/
335.Pannek, J., et al. Clinical usefulness of the memokath stent as a second-line procedure after sphincterotomy failure. J Endourol, 2011. 25: 335.
https://pubmed.ncbi.nlm.nih.gov/20977372/
336.Polguer, T., et al. [Treatment of detrusor-striated sphincter dyssynergia with permanent nitinol urethral stent: results after a minimum follow-up of 2 years]. Prog Urol, 2012. 22: 1058.
https://pubmed.ncbi.nlm.nih.gov/23182120/
337.van der Merwe, A., et al. Outcome of dual flange metallic urethral stents in the treatment of neuropathic bladder dysfunction after spinal cord injury. J Endourol, 2012. 26: 1210.
https://pubmed.ncbi.nlm.nih.gov/22519741/
338.Brindley, G.S. An implant to empty the bladder or close the urethra. J Neurol Neurosurg Psychiatry, 1977. 40: 358.
https://pubmed.ncbi.nlm.nih.gov/406364/
339.Krasmik, D., et al. Urodynamic results, clinical efficacy, and complication rates of sacral intradural deafferentation and sacral anterior root stimulation in patients with neurogenic lower urinary tract dysfunction resulting from complete spinal cord injury. Neurourol Urodyn, 2014. 33: 1202.
https://pubmed.ncbi.nlm.nih.gov/24038405/
340.Benard, A., et al. Comparative cost-effectiveness analysis of sacral anterior root stimulation for rehabilitation of bladder dysfunction in spinal cord injured patients. Neurosurgery, 2013. 73: 600.
https://pubmed.ncbi.nlm.nih.gov/23787880/
341.Martens, F.M., et al. Quality of life in complete spinal cord injury patients with a Brindley bladder stimulator compared to a matched control group. Neurourol Urodyn, 2011. 30: 551.
https://pubmed.ncbi.nlm.nih.gov/21328472/
342.Krebs, J., et al. Long-term course of sacral anterior root stimulation in spinal cord injured individuals: The fate of the detrusor. Neurourol Urodyn, 2017. 36: 1596.
https://pubmed.ncbi.nlm.nih.gov/27778371/
343.Krebs, J., et al. Charcot arthropathy of the spine in spinal cord injured individuals with sacral deafferentation and anterior root stimulator implantation. Neurourol Urodyn, 2016. 35: 241.
https://pubmed.ncbi.nlm.nih.gov/25524388/
344.Nagib, A., et al. Successful control of selective anterior sacral rhizotomy for treatment of spastic bladder and ureteric reflux in paraplegics. Med Serv J Can, 1966. 22: 576.
https://pubmed.ncbi.nlm.nih.gov/5966992/
345.Schneidau, T., et al. Selective sacral rhizotomy for the management of neurogenic bladders in spina bifida patients: long-term followup. J Urol, 1995. 154: 766.
https://pubmed.ncbi.nlm.nih.gov/7609174/
346.Young, B., et al. Percutaneous sacral rhizotomy for neurogenic detrusor hyperreflexia. J Neurosurg, 1980. 53: 85.
https://pubmed.ncbi.nlm.nih.gov/7411212/
347.Koldewijn, E.L., et al. Bladder compliance after posterior sacral root rhizotomies and anterior sacral root stimulation. J Urol, 1994. 151: 955.
https://pubmed.ncbi.nlm.nih.gov/8126835/
348.Singh, G., et al. Intravesical oxybutynin in patients with posterior rhizotomies and sacral anterior root stimulators. Neurourol Urodyn, 1995. 14: 65.
https://pubmed.ncbi.nlm.nih.gov/7742851/
349.Van Kerrebroeck, P.E., et al. Results of the treatment of neurogenic bladder dysfunction in spinal cord injury by sacral posterior root rhizotomy and anterior sacral root stimulation. J Urol, 1996. 155: 1378.
https://pubmed.ncbi.nlm.nih.gov/8632580/
350.Kutzenberger, J.S. Surgical therapy of neurogenic detrusor overactivity (hyperreflexia) in paraplegic patients by sacral deafferentation and implant driven micturition by sacral anterior root stimulation: methods, indications, results, complications, and future prospects. Acta Neurochir, 2007. 97: 333.
https://pubmed.ncbi.nlm.nih.gov/17691394/
351.Bhadra, N., et al. Selective suppression of sphincter activation during sacral anterior nerve root stimulation. Neurourol Urodyn, 2002. 21: 55.
https://pubmed.ncbi.nlm.nih.gov/11835425/
352.Kirkham, A.P., et al. Neuromodulation through sacral nerve roots 2 to 4 with a Finetech-Brindley sacral posterior and anterior root stimulator. Spinal Cord, 2002. 40: 272.
https://pubmed.ncbi.nlm.nih.gov/12037708/
353.Schumacher, S., et al. Extradural cold block for selective neurostimulation of the bladder: development of a new technique. J Urol, 1999. 161: 950.
https://pubmed.ncbi.nlm.nih.gov/10022732/
354.Greenberg, D.R., et al. Sacral Nerve Stimulation in Parkinson’s Disease Patients With Overactive Bladder Symptoms. Urology, 2020. 144: 99.
https://pubmed.ncbi.nlm.nih.gov/32681915/
355.Kessler, T.M., et al. Sacral neuromodulation for neurogenic lower urinary tract dysfunction: systematic review and meta-analysis. Eur Urol, 2010. 58: 865.
https://pubmed.ncbi.nlm.nih.gov/20934242/
356.van Ophoven, A., et al. Systematic Literature Review and Meta-Analysis of Sacral Neuromodulation (SNM) in Patients with Neurogenic Lower Urinary Tract Dysfunction (nLUTD): Over 20 Years’ Experience and Future Directions. Adv Ther, 2021. 38: 1987.
https://pubmed.ncbi.nlm.nih.gov/33713279/
357.Jörg, E., et al. Deep brain stimulation effects on lower urinary tract function: Systematic review and meta-analysis. Parkinsonism Relat Disord, 2020. 79: 65.
https://pubmed.ncbi.nlm.nih.gov/32889502/
358.Zhang, Y.H., et al. Enveloping the bladder with displacement of flap of the rectus abdominis muscle for the treatment of neurogenic bladder. J Urol, 1990. 144: 1194.
https://pubmed.ncbi.nlm.nih.gov/2146404/
359.Stenzl, A., et al. Restoration of voluntary emptying of the bladder by transplantation of innervated free skeletal muscle. Lancet, 1998. 351: 1483.
https://pubmed.ncbi.nlm.nih.gov/9605805/
360.Gakis, G., et al. Functional detrusor myoplasty for bladder acontractility: long-term results. J Urol, 2011. 185: 593.
https://pubmed.ncbi.nlm.nih.gov/21168866/
361.Ninkovic, M., et al. The latissimus dorsi detrusor myoplasty for functional treatment of bladder acontractility. Clin Plast Surg, 2012. 39: 507.
https://pubmed.ncbi.nlm.nih.gov/23036300/
362.Duel, B.P., et al. Alternative techniques for augmentation cystoplasty. J Urol, 1998. 159: 998.
https://pubmed.ncbi.nlm.nih.gov/9474216/
363.Snow, B.W., et al. Bladder autoaugmentation. Urol Clin North Am, 1996. 23: 323.
https://pubmed.ncbi.nlm.nih.gov/8659030/
364.Stohrer, M., et al. Bladder auto-augmentation--an alternative for enterocystoplasty: preliminary results. Neurourol Urodyn, 1995. 14: 11.
https://pubmed.ncbi.nlm.nih.gov/7742844/
365.Stohrer, M., et al. Bladder autoaugmentation in adult patients with neurogenic voiding dysfunction. Spinal Cord, 1997. 35: 456.
https://pubmed.ncbi.nlm.nih.gov/9232751/
366.Vainrib, M., et al. Differences in urodynamic study variables in adult patients with neurogenic bladder and myelomeningocele before and after augmentation enterocystoplasty. Neurourol Urodyn, 2013. 32: 250.
https://pubmed.ncbi.nlm.nih.gov/22965686/
367.Krebs, J., et al. Functional outcome of supratrigonal cystectomy and augmentation ileocystoplasty in adult patients with refractory neurogenic lower urinary tract dysfunction. Neurourol Urodyn, 2016. 35.
https://pubmed.ncbi.nlm.nih.gov/25524480/
368.Hoen, L., et al. Long-term effectiveness and complication rates of bladder augmentation in patients with neurogenic bladder dysfunction: A systematic review. Neurourol Urodyn, 2017. 07: 07.
https://pubmed.ncbi.nlm.nih.gov/28169459/
369.Myers, J.B., et al. The effects of augmentation cystoplasty and botulinum toxin injection on patient-reported bladder function and quality of life among individuals with spinal cord injury performing clean intermittent catheterization. Neurourol Urodyn, 2019. 38: 285.
https://pubmed.ncbi.nlm.nih.gov/30375055/
370.Mitsui, T., et al. Preoperative renal scar as a risk factor of postoperative metabolic acidosis following ileocystoplasty in patients with neurogenic bladder. Spinal Cord, 2014. 52: 292.
https://pubmed.ncbi.nlm.nih.gov/24469144/
371.Perrouin-Verbe, M.A., et al. Long-term functional outcomes of augmentation cystoplasty in adult spina bifida patients: A single-center experience in a multidisciplinary team. Neurourol Urodyn, 2019. 38: 330.
https://pubmed.ncbi.nlm.nih.gov/30350892/
372.Frainey, B.T., et al. Complications of Pediatric Bladder Reconstruction in the Adult Patient. Curr Bladder Dysf Rep, 2020. 15: 173.
https://link.springer.com/article/10.1007/s11884-020-00584-2
373.Moreno, J.G., et al. Improved quality of life and sexuality with continent urinary diversion in quadriplegic women with umbilical stoma. Arch Phys Med Rehabil, 1995. 76: 758.
https://pubmed.ncbi.nlm.nih.gov/7632132/
374.Peterson, A.C., et al. Urinary diversion in patients with spinal cord injury in the United States. Urology, 2012. 80: 1247.
https://pubmed.ncbi.nlm.nih.gov/23206770/
375.Sylora, J.A., et al. Intermittent self-catheterization by quadriplegic patients via a catheterizable Mitrofanoff channel. J Urol, 1997. 157: 48.
https://pubmed.ncbi.nlm.nih.gov/8976213/
376.Van Savage, J.G., et al. Transverse retubularized sigmoidovesicostomy continent urinary diversion to the umbilicus. J Urol, 2001. 166: 644.
https://pubmed.ncbi.nlm.nih.gov/11458110/
377.Vanni, A.J., et al. Ileovesicostomy for the neurogenic bladder patient: outcome and cost comparison of open and robotic assisted techniques. Urology, 2011. 77: 1375.
https://pubmed.ncbi.nlm.nih.gov/21146864/
378.Wiener, J.S., et al. Bladder augmentation versus urinary diversion in patients with spina bifida in the United States. J Urol, 2011. 186: 161.
https://pubmed.ncbi.nlm.nih.gov/21575969/
379.Cheng, P.J., et al. Contemporary multicenter outcomes of continent cutaneous ileocecocystoplasty in the adult population over a 10-year period: A Neurogenic Bladder Research Group study. Neurourol Urodyn, 2020. 39: 1771.
https://pubmed.ncbi.nlm.nih.gov/32506711/
380.Phe, V., et al. Continent catheterizable tubes/stomas in adult neuro-urological patients: A systematic review. Neurourol Urodyn, 2017.
https://pubmed.ncbi.nlm.nih.gov/28139848/
381.Atan, A., et al. Advantages and risks of ileovesicostomy for the management of neuropathic bladder. Urology, 1999. 54: 636.
https://pubmed.ncbi.nlm.nih.gov/10510920/
382.Cass, A.S., et al. A 22-year followup of ileal conduits in children with a neurogenic bladder. J Urol, 1984. 132: 529.
https://pubmed.ncbi.nlm.nih.gov/6471190/
383.Hald, T., et al. Vesicostomy--an alternative urine diversion operation. Long term results. Scand
J Urol Nephrol, 1978. 12: 227.
https://pubmed.ncbi.nlm.nih.gov/725543/
384.Schwartz, S.L., et al. Incontinent ileo-vesicostomy urinary diversion in the treatment of lower urinary tract dysfunction. J Urol, 1994. 152: 99.
https://pubmed.ncbi.nlm.nih.gov/8201699/
385.Sakhri, R., et al. [Laparoscopic cystectomy and ileal conduit urinary diversion for neurogenic bladders and related conditions. Morbidity and better quality of life]. Prog Urol, 2015. 25: 342.
https://pubmed.ncbi.nlm.nih.gov/25726693/
386.Akakpo, W., et al. Outcomes of ileal conduit urinary diversion in patients with multiple sclerosis. Neurourol Urodyn, 2020. 39: 771.
https://pubmed.ncbi.nlm.nih.gov/31951678/
387.Mazouin, C., et al. Robot-assisted cystectomy and ileal conduit for neurogenic bladder : comparison of extracorporeal vs intracorporeal urinary diversion. J Endourol, 2021.
https://pubmed.ncbi.nlm.nih.gov/33499755
388.Herschorn, S., et al. Urinary undiversion in adults with myelodysplasia: long-term followup. J Urol, 1994. 152: 329.
https://pubmed.ncbi.nlm.nih.gov/8015064/
389.Mukai, S., et al. Retrospective study for risk factors for febrile UTI in spinal cord injury patients with routine concomitant intermittent catheterization in outpatient settings. Spinal Cord, 2016. 54: 69.
https://pubmed.ncbi.nlm.nih.gov/26458969/
390.Vasudeva, P., et al. Factors implicated in pathogenesis of urinary tract infections in neurogenic bladders: some revered, few forgotten, others ignored. Neurourol Urodyn, 2014. 33: 95.
https://pubmed.ncbi.nlm.nih.gov/23460489/
391.Lenherr, S.M., et al. Glycemic Control and Urinary Tract Infections in Women with Type 1 Diabetes: Results from the DCCT/EDIC. J Urol, 2016. 196: 1129.
https://pubmed.ncbi.nlm.nih.gov/27131462/
392.Bakke, A., et al. Bacteriuria in patients treated with clean intermittent catheterization. Scand J Infect Dis, 1991. 23: 577.
https://pubmed.ncbi.nlm.nih.gov/1767253/
393.Waites, K.B., et al. Epidemiology and risk factors for urinary tract infection following spinal cord injury. Arch Phys Med Rehabil, 1993. 74: 691.
https://pubmed.ncbi.nlm.nih.gov/8328888/
394.Nicolle, L.E., et al. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis, 2005. 40: 643.
https://pubmed.ncbi.nlm.nih.gov/15714408/
395.Wang, W., et al. A risk prediction model of urinary tract infections for patients with neurogenic bladder. Int J Neurosci, 2021. 131: 31.
https://pubmed.ncbi.nlm.nih.gov/32075472/
396.Pannek, J. Treatment of urinary tract infection in persons with spinal cord injury: guidelines, evidence, and clinical practice. A questionnaire-based survey and review of the literature. J Spinal Cord Med, 2011. 34: 11.
https://pubmed.ncbi.nlm.nih.gov/21528621/
397.Alavinia, S.M., et al. Enhancing quality practice for prevention and diagnosis of urinary tract infection during inpatient spinal cord rehabilitation. J Spinal Cord Med, 2017. 40: 803.
https://pubmed.ncbi.nlm.nih.gov/28872426/
398.Deville, W.L., et al. The urine dipstick test useful to rule out infections. A meta-analysis of the accuracy. BMC Urol, 2004. 4: 4.
https://pubmed.ncbi.nlm.nih.gov/15175113/
399.Hoffman, J.M., et al. Nitrite and leukocyte dipstick testing for urinary tract infection in individuals with spinal cord injury. J Spinal Cord Med, 2004. 27: 128.
https://pubmed.ncbi.nlm.nih.gov/15162883/
400.Biering-Sorensen, F., et al. Urinary tract infections in patients with spinal cord lesions: treatment and prevention. Drugs, 2001. 61: 1275.
https://pubmed.ncbi.nlm.nih.gov/11511022/
401.Everaert, K., et al. Urinary tract infections in spinal cord injury: prevention and treatment guidelines. Acta Clin Belg, 2009. 64: 335.
https://pubmed.ncbi.nlm.nih.gov/19810421/
402.Clark, R., et al. The ability of prior urinary cultures results to predict future culture results in neurogenic bladder patients. Neurourol Urodyn, 2018. 37: 2645.
https://pubmed.ncbi.nlm.nih.gov/29799144/
403.Pannek, J., et al. Treatment of Complicated Urinary Tract Infections in Individuals with Chronic Neurogenic Lower Urinary Tract Dysfunction: Are Antibiotics Mandatory? Urol Int, 2018.
https://pubmed.ncbi.nlm.nih.gov/29649808/
404.Del Popolo, G., et al. Recurrent bacterial symptomatic cystitis: A pilot study on a new natural option for treatment. Arch Ital Urol Androl, 2018. 9: 101.
https://pubmed.ncbi.nlm.nih.gov/29974728/
405.Jia, C., et al. Detrusor botulinum toxin A injection significantly decreased urinary tract infection in patients with traumatic spinal cord injury. Spinal Cord, 2013. 51: 487.
https://pubmed.ncbi.nlm.nih.gov/23357928/
406.Waites, K.B., et al. Evaluation of 3 methods of bladder irrigation to treat bacteriuria in persons with neurogenic bladder. J Spinal Cord Med, 2006. 29: 217.
https://pubmed.ncbi.nlm.nih.gov/16859225/
407.Gallien, P., et al. Cranberry versus placebo in the prevention of urinary infections in multiple sclerosis: a multicenter, randomized, placebo-controlled, double-blind trial. Mult Scler, 2014. 20: 1252.
https://pubmed.ncbi.nlm.nih.gov/24402038/
408.Toh, S.L., et al. Probiotics [LGG-BB12 or RC14-GR1] versus placebo as prophylaxis for urinary tract infection in persons with spinal cord injury [ProSCIUTTU]: a randomised controlled trial. Spinal Cord, 2019.
https://pubmed.ncbi.nlm.nih.gov/30814670/
409.Lee, B.S., et al. Methenamine hippurate for preventing urinary tract infections. Cochrane Database Syst Rev, 2012. 10: Cd003265.
https://pubmed.ncbi.nlm.nih.gov/23076896/
410.Günther, M., et al. Harnwegsinfektprophylaxe. Urinansäuerung mittels L-Methionin bei neurogener Blasenfunktionsstörung. Urologe B, 2002. 42: 218.
411.Hachen, H.J. Oral immunotherapy in paraplegic patients with chronic urinary tract infections: a double-blind, placebo-controlled trial. J Urol, 1990. 143: 759.
https://pubmed.ncbi.nlm.nih.gov/2179584/
412.Krebs, J., et al. Effects of oral immunomodulation therapy on urinary tract infections in individuals with chronic spinal cord injury-A retrospective cohort study. Neurourol Urodyn, 2018.
https://pubmed.ncbi.nlm.nih.gov/30350886/
413.Poirier, C., et al. Prevention of urinary tract infections by antibiotic cycling in spinal cord injury patients and low emergence of multidrug resistant bacteria. Med Mal Infect, 2016. 16: 16.
https://pubmed.ncbi.nlm.nih.gov/27321478/
414.Darouiche, R.O., et al. Multicenter randomized controlled trial of bacterial interference for prevention of urinary tract infection in patients with neurogenic bladder. Urology, 2011. 78: 341.
https://pubmed.ncbi.nlm.nih.gov/21683991/
415.Pannek, J., et al. Usefulness of classical homeopathy for the prophylaxis of recurrent urinary tract infections in individuals with chronic neurogenic lower urinary tract dysfunction. J Spinal Cord Med, 2018: 1.
https://pubmed.ncbi.nlm.nih.gov/29485355/
416.Cox, L., et al. Gentamicin bladder instillations decrease symptomatic urinary tract infections in neurogenic bladder patients on intermittent catheterization. Can Urol Assoc J, 2017. 11: E350.
https://pubmed.ncbi.nlm.nih.gov/29382457/
417.Pannek, J., et al. Usefulness of classical homoeopathy for the prevention of urinary tract infections in patients with neurogenic bladder dysfunction: A case series. Indian J Res Homoeopathy, 2014. 8: 31.
https://www.ijrh.org/article.asp?issn=0974-7168;year=2014;volume=8;issue=1;spage=31;epage=36;
aulast=Pannek
418.Rees, P.M., et al. Sexual function in men and women with neurological disorders. Lancet, 2007.
369: 512.
https://pubmed.ncbi.nlm.nih.gov/17292771/
419.Lombardi, G., et al. Management of sexual dysfunction due to central nervous system disorders: a systematic review. BJU Int, 2015. 115 Suppl 6: 47.
https://pubmed.ncbi.nlm.nih.gov/25599613/
420.Jungwirth, A., et al., EAU Guidelines on Male Infertility, in Presented at the 30th Annual Congress in Madrid. 2015.
https://uroweb.org/wp-content/uploads/EAU-Guidelines-Male-Infertility-20151.pdf
421.Hatzimouratidis, K., et al., EAU guidelines on Male Sexual Dysfunction and Premature Ejaculation., in Presented at the 30th Annual Congress in Madrid. 2014.
https://uroweb.org/wp-content/uploads/14-Male-Sexual-Dysfunction_LR.pdf
422.Foley, F.W., Sexuality, In: Multiple Sclerosis: A Guide for Families K. RC., Editor. 2006, Demos Medical Publishing: New York, USA.
423.Annon, J.S., PLISSIT Therapy in Handbook of Innovative Psychotherapies. , R. Corsini, Editor. 1981, Wiley & Sons: New York.
424.Fragala, E., et al. Relationship between urodynamic findings and sexual function in multiple sclerosis patients with lower urinary tract dysfunction. Eur J Neurol, 2015. 22: 485.
https://pubmed.ncbi.nlm.nih.gov/25410608/
425.Game, X., et al. Sexual function of young women with myelomeningocele. J Pediatr Urol, 2014. 10: 418.
https://pubmed.ncbi.nlm.nih.gov/23992838/
426.Chen, L., et al. Phosphodiesterase 5 Inhibitors for the Treatment of Erectile Dysfunction: A Trade-off Network Meta-analysis. Eur Urol, 2015. 68: 674.
https://pubmed.ncbi.nlm.nih.gov/25817916/
427.Fowler, C.J., et al. A double blind, randomised study of sildenafil citrate for erectile dysfunction in men with multiple sclerosis. J Neurol Neurosurg Psychiatry, 2005. 76: 700.
https://pubmed.ncbi.nlm.nih.gov/15834030/
428.Lombardi, G., et al. Efficacy and safety of tadalafil for erectile dysfunction in patients with multiple sclerosis. J Sex Med, 2010. 7: 2192.
https://pubmed.ncbi.nlm.nih.gov/20384939/
429.Safarinejad, M.R. Evaluation of the safety and efficacy of sildenafil citrate for erectile dysfunction in men with multiple sclerosis: a double-blind, placebo controlled, randomized study. J Urol, 2009. 181: 252.
https://pubmed.ncbi.nlm.nih.gov/19013598/
430.Streur, C.S., et al. Sexual Function of Men and Women With Spina Bifida: A Scoping Literature Review. Sex Med Rev, 2021. 9: 244.
https://pubmed.ncbi.nlm.nih.gov/33608247/
431.Lombardi, G., et al. Ten years of phosphodiesterase type 5 inhibitors in spinal cord injured patients. J Sex Med, 2009. 6: 1248.
https://pubmed.ncbi.nlm.nih.gov/19210710/
432.Lombardi, G., et al. Treating erectile dysfunction and central neurological diseases with oral phosphodiesterase type 5 inhibitors. Review of the literature. J Sex Med, 2012. 9: 970.
https://pubmed.ncbi.nlm.nih.gov/22304626/
433.Cardenas, D.D., et al. Two phase 3, multicenter, randomized, placebo-controlled clinical trials of fampridine-SR for treatment of spasticity in chronic spinal cord injury. Spinal Cord, 2014. 52: 70.
https://pubmed.ncbi.nlm.nih.gov/24216616/
434.Strebel, R.T., et al. Apomorphine sublingual as primary or secondary treatment for erectile dysfunction in patients with spinal cord injury. BJU Int, 2004. 93: 100.
https://pubmed.ncbi.nlm.nih.gov/14678378/
435.Pohanka, M., et al. The long-lasting improvement of sexual dysfunction in patients with advanced, fluctuating Parkinson’s disease induced by pergolide: evidence from the results of an open, prospective, one-year trial. Parkinsonism Relat Disord, 2005. 11: 509.
https://pubmed.ncbi.nlm.nih.gov/15994112/
436.Chancellor, M.B., et al. Prospective comparison of topical minoxidil to vacuum constriction device and intracorporeal papaverine injection in treatment of erectile dysfunction due to spinal cord injury. Urology, 1994. 43: 365.
https://pubmed.ncbi.nlm.nih.gov/8134992/
437.Cookson, M.S., et al. Long-term results with vacuum constriction device. J Urol, 1993. 149: 290.
https://pubmed.ncbi.nlm.nih.gov/8426404/
438.Denil, J., et al. Vacuum erection device in spinal cord injured men: patient and partner satisfaction. Arch Phys Med Rehabil, 1996. 77: 750.
https://pubmed.ncbi.nlm.nih.gov/8702367/
439.Levine, L.A. External devices for treatment of erectile dysfunction. Endocrine, 2004. 23: 157.
https://pubmed.ncbi.nlm.nih.gov/15146095/
440.Levine, L.A., et al. Vacuum constriction and external erection devices in erectile dysfunction. Urol Clin North Am, 2001. 28: 335.
https://pubmed.ncbi.nlm.nih.gov/11402585/
441.Bella, A.J., et al. Intracavernous pharmacotherapy for erectile dysfunction. Endocrine, 2004. 23: 149.
https://pubmed.ncbi.nlm.nih.gov/15146094/
442.Bodner, D.R., et al. The application of intracavernous injection of vasoactive medications for erection in men with spinal cord injury. J Urol, 1987. 138: 310.
https://pubmed.ncbi.nlm.nih.gov/3599245/
443.Deforge, D., et al. Male erectile dysfunction following spinal cord injury: a systematic review. Spinal Cord, 2006. 44: 465.
https://pubmed.ncbi.nlm.nih.gov/16317419/
444.Dinsmore, W.W., et al. Treating men with predominantly nonpsychogenic erectile dysfunction with intracavernosal vasoactive intestinal polypeptide and phentolamine mesylate in a novel auto-injector system: a multicentre double-blind placebo-controlled study. BJU Int, 1999. 83: 274.
https://pubmed.ncbi.nlm.nih.gov/10233493/
445.Hirsch, I.H., et al. Use of intracavernous injection of prostaglandin E1 for neuropathic erectile dysfunction. Paraplegia, 1994. 32: 661.
https://pubmed.ncbi.nlm.nih.gov/7831071/
446.Kapoor, V.K., et al. Intracavernous papaverine for impotence in spinal cord injured patients. Paraplegia, 1993. 31: 675.
https://pubmed.ncbi.nlm.nih.gov/8259331/
447.Vidal, J., et al. Intracavernous pharmacotherapy for management of erectile dysfunction in multiple sclerosis patients. Rev Neurol, 1995. 23: 269.
https://pubmed.ncbi.nlm.nih.gov/7497173/
448.Bodner, D.R., et al. Intraurethral alprostadil for treatment of erectile dysfunction in patients with spinal cord injury. Urology, 1999. 53: 199.
https://pubmed.ncbi.nlm.nih.gov/9886612/
449.Gross, A.J., et al. Penile prostheses in paraplegic men. Br J Urol, 1996. 78: 262.
https://pubmed.ncbi.nlm.nih.gov/8813925/
450.Kimoto, Y., et al. Penile prostheses for the management of the neuropathic bladder and sexual dysfunction in spinal cord injury patients: long term follow up. Paraplegia, 1994. 32: 336.
https://pubmed.ncbi.nlm.nih.gov/8058351/
451.Zermann, D.H., et al. Penile prosthetic surgery in neurologically impaired patients: long-term followup. J Urol, 2006. 175: 1041.
https://pubmed.ncbi.nlm.nih.gov/16469612/
452.Fode, M., et al. Male sexual dysfunction and infertility associated with neurological disorders. Asian J Androl, 2012. 14: 61.
https://pubmed.ncbi.nlm.nih.gov/22138899/
453.Lim, T.C., et al. A simple technique to prevent retrograde ejaculation during assisted ejaculation. Paraplegia, 1994. 32: 142.
https://pubmed.ncbi.nlm.nih.gov/8008416/
454.Philippon, M., et al. Successful pregnancies and healthy live births using frozen-thawed sperm retrieved by a new modified Hotchkiss procedure in males with retrograde ejaculation: first case series. Basic Clin Androl, 2015. 25: 5.
https://pubmed.ncbi.nlm.nih.gov/26034605/
455.Arafa, M.M., et al. Prostatic massage: a simple method of semen retrieval in men with spinal cord injury. Int J Androl, 2007. 30: 170.
https://pubmed.ncbi.nlm.nih.gov/17298549/
456.Kolettis, P.N., et al. Fertility outcomes after electroejaculation in men with spinal cord injury. Fertil Steril, 2002. 78: 429.
https://pubmed.ncbi.nlm.nih.gov/12137889/
457.Chehensse, C., et al. The spinal control of ejaculation revisited: a systematic review and meta-analysis of anejaculation in spinal cord injured patients. Hum Reprod Update, 2013. 19: 507.
https://pubmed.ncbi.nlm.nih.gov/23820516/
458.Beretta, G., et al. Reproductive aspects in spinal cord injured males. Paraplegia, 1989. 27: 113.
https://pubmed.ncbi.nlm.nih.gov/2717193/
459.Brackett, N.L., et al. Application of 2 vibrators salvages ejaculatory failures to 1 vibrator during penile vibratory stimulation in men with spinal cord injuries. J Urol, 2007. 177: 660.
https://pubmed.ncbi.nlm.nih.gov/17222653/
460.Sonksen, J., et al. Ejaculation induced by penile vibratory stimulation in men with spinal cord injuries. The importance of the vibratory amplitude. Paraplegia, 1994. 32: 651.
https://pubmed.ncbi.nlm.nih.gov/7831070/
461.Claydon, V.E., et al. Cardiovascular responses to vibrostimulation for sperm retrieval in men with spinal cord injury. J Spinal Cord Med, 2006. 29: 207.
https://pubmed.ncbi.nlm.nih.gov/16859224/
462.Ekland, M.B., et al. Incidence of autonomic dysreflexia and silent autonomic dysreflexia in men with spinal cord injury undergoing sperm retrieval: implications for clinical practice. J Spinal Cord Med, 2008. 31: 33.
https://pubmed.ncbi.nlm.nih.gov/18533409/
463.Soler, J.M., et al. Midodrine improves ejaculation in spinal cord injured men. J Urol, 2007. 178: 2082.
https://pubmed.ncbi.nlm.nih.gov/17869290/
464.Pecori, C., et al. Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study. BMC Neurol, 2014. 14: 114.
https://pubmed.ncbi.nlm.nih.gov/24884599/
465.Brackett, N.L., et al. Treatment of infertility in men with spinal cord injury. Nat Rev Urol, 2010. 7: 162.
https://pubmed.ncbi.nlm.nih.gov/20157304/
466.Raviv, G., et al. Testicular sperm retrieval and intra cytoplasmic sperm injection provide favorable outcome in spinal cord injury patients, failing conservative reproductive treatment. Spinal Cord, 2013. 51: 642.
https://pubmed.ncbi.nlm.nih.gov/23689394/
467.Schatte, E.C., et al. Treatment of infertility due to anejaculation in the male with electroejaculation and intracytoplasmic sperm injection. J Urol, 2000. 163: 1717.
https://pubmed.ncbi.nlm.nih.gov/10799167/
468.Shieh, J.Y., et al. A protocol of electroejaculation and systematic assisted reproductive technology achieved high efficiency and efficacy for pregnancy for anejaculatory men with spinal cord injury. Arch Phys Med Rehabil, 2003. 84: 535.
https://pubmed.ncbi.nlm.nih.gov/12690592/
469.Taylor, Z., et al. Contribution of the assisted reproductive technologies to fertility in males suffering spinal cord injury. Aust N Z J Obstet Gynaecol, 1999. 39: 84.
https://pubmed.ncbi.nlm.nih.gov/10099757/
470.Rutkowski, S.B., et al. The influence of bladder management on fertility in spinal cord injured males. Paraplegia, 1995. 33: 263.
https://pubmed.ncbi.nlm.nih.gov/7630651/
471.Hamed, S.A., et al. Seminal fluid analysis and testicular volume in adults with epilepsy receiving valproate. J Clin Neurosci, 2015. 22: 508.
https://pubmed.ncbi.nlm.nih.gov/25636832/
472.Ohl, D.A., et al. Electroejaculation versus vibratory stimulation in spinal cord injured men: sperm quality and patient preference. J Urol, 1997. 157: 2147.
https://pubmed.ncbi.nlm.nih.gov/9146603/
473.Brackett, N.L., et al. Semen quality of spinal cord injured men is better when obtained by vibratory stimulation versus electroejaculation. J Urol, 1997. 157: 151.
https://pubmed.ncbi.nlm.nih.gov/8976239/
474.Brackett, N.L., et al. Semen retrieval in men with spinal cord injury is improved by interrupting current delivery during electroejaculation. J Urol, 2002. 167: 201.
https://pubmed.ncbi.nlm.nih.gov/11743305/
475.DeForge, D., et al. Fertility following spinal cord injury: a systematic review. Spinal Cord, 2005. 43: 693.
https://pubmed.ncbi.nlm.nih.gov/15951744/
476.Ferreiro-Velasco, M.E., et al. Sexual issues in a sample of women with spinal cord injury. Spinal Cord, 2005. 43: 51.
https://pubmed.ncbi.nlm.nih.gov/15303115/
477.Kreuter, M., et al. Sexuality and sexual life in women with spinal cord injury: a controlled study.
J Rehabil Med, 2008. 40: 61.
https://pubmed.ncbi.nlm.nih.gov/18176739/
478.Kreuter, M., et al. Sexual adjustment and quality of relationship in spinal paraplegia: a controlled study. Arch Phys Med Rehabil, 1996. 77: 541.
https://pubmed.ncbi.nlm.nih.gov/8831469/
479.Kessler, T.M., et al. Sexual dysfunction in multiple sclerosis. Expert Rev Neurother, 2009. 9: 341.
https://pubmed.ncbi.nlm.nih.gov/19271943/
480.Lew-Starowicz, M., et al. Prevalence of Sexual Dysfunctions Among Women with Multiple Sclerosis. Sex Disabil, 2013. 31: 141.
https://pubmed.ncbi.nlm.nih.gov/23704801/
481.Motta, G.L., et al. The impact of neurogenic bladder bowel dysfunction in the sexuality of female spina bifida patients. J Pediatr Urol, 2021.
https://pubmed.ncbi.nlm.nih.gov/33546979/
482.Alexander, M., et al. Spinal cord injuries and orgasm: a review. J Sex Marital Ther, 2008. 34: 308.
https://pubmed.ncbi.nlm.nih.gov/18576233/
483.McAlonan, S. Improving sexual rehabilitation services: the patient’s perspective. Am J Occup Ther, 1996. 50: 826.
https://pubmed.ncbi.nlm.nih.gov/8947375/
484.Schopp, L.H., et al. Impact of comprehensive gynecologic services on health maintenance behaviours among women with spinal cord injury. Disabil Rehabil, 2002. 24: 899.
https://pubmed.ncbi.nlm.nih.gov/12519485/
485.Reitz, A., et al. Impact of spinal cord injury on sexual health and quality of life. Int J Impot Res, 2004. 16: 167.
https://pubmed.ncbi.nlm.nih.gov/14973522/
486.Harrison, J., et al. Factors associated with sexual functioning in women following spinal cord injury. Paraplegia, 1995. 33: 687.
https://pubmed.ncbi.nlm.nih.gov/8927405/
487.Westgren, N., et al. Sexuality in women with traumatic spinal cord injury. Acta Obstet Gynecol Scand, 1997. 76: 977.
https://pubmed.ncbi.nlm.nih.gov/9435740/
488.Fruhauf, S., et al. Efficacy of psychological interventions for sexual dysfunction: a systematic review and meta-analysis. Arch Sex Behav, 2013. 42: 915.
https://pubmed.ncbi.nlm.nih.gov/23559141/
489.Sipski, M.L., et al. Physiologic parameters associated with sexual arousal in women with incomplete spinal cord injuries. Arch Phys Med Rehabil, 1997. 78: 305.
https://pubmed.ncbi.nlm.nih.gov/9084355/
490.Sipski, M.L., et al. Sexual arousal and orgasm in women: effects of spinal cord injury. Ann Neurol, 2001. 49: 35.
https://pubmed.ncbi.nlm.nih.gov/11198294/
491.Sukumaran, S.C., et al. Polytherapy increases the risk of infertility in women with epilepsy. Neurology, 2010. 75: 1351.
https://pubmed.ncbi.nlm.nih.gov/20938026/
492.Axel, S.J. Spinal cord injured women’s concerns: menstruation and pregnancy. Rehabil Nurs, 1982. 7: 10.
https://pubmed.ncbi.nlm.nih.gov/6921826/
493.Jackson, A.B., et al. A multicenter study of women’s self-reported reproductive health after spinal cord injury. Arch Phys Med Rehabil, 1999. 80: 1420.
https://pubmed.ncbi.nlm.nih.gov/10569436/
494.Baker, E.R., et al. Pregnancy in spinal cord injured women. Arch Phys Med Rehabil, 1996. 77: 501.
https://pubmed.ncbi.nlm.nih.gov/8629929/
495.Baker, E.R., et al. Risks associated with pregnancy in spinal cord-injured women. Obstet Gynecol, 1992. 80: 425.
https://pubmed.ncbi.nlm.nih.gov/1495699/
496.Bertschy, S., et al. Delivering care under uncertainty: Swiss providers’ experiences in caring for women with spinal cord injury during pregnancy and childbirth - an expert interview study. BMC Pregnancy Childbirth, 2016. 16: 181.
https://pubmed.ncbi.nlm.nih.gov/27443838/
497.Le Liepvre, H., et al. Pregnancy in spinal cord-injured women, a cohort study of 37 pregnancies in 25 women. Spinal Cord, 2017. 55: 167.
https://pubmed.ncbi.nlm.nih.gov/27670808/
498.Skowronski, E., et al. Obstetric management following traumatic tetraplegia: case series and literature review. Aust N Z J Obstet Gynaecol, 2008. 48: 485.
https://pubmed.ncbi.nlm.nih.gov/19032665/
499.Cross, L.L., et al. Pregnancy, labor and delivery post spinal cord injury. Paraplegia, 1992. 30: 890.
https://pubmed.ncbi.nlm.nih.gov/1287543/
500.Hughes, S.J., et al. Management of the pregnant woman with spinal cord injuries. Br J Obstet Gynaecol, 1991. 98: 513.
https://pubmed.ncbi.nlm.nih.gov/1873238/
501.Dannels, A., et al. The perimenopause experience for women with spinal cord injuries. SCI Nurs, 2004. 21: 9.
https://pubmed.ncbi.nlm.nih.gov/15176344/
502.Amato, M.P., et al. Management of pregnancy-related issues in multiple sclerosis patients: the need for an interdisciplinary approach. Neurol Sci, 2017. 38: 1849.
https://pubmed.ncbi.nlm.nih.gov/28770366/
503.Delaney, K.E., et al. Multiple sclerosis and sexual dysfunction: A need for further education and interdisciplinary care. NeuroRehabilitation, 2017. 41: 317.
https://pubmed.ncbi.nlm.nih.gov/29036844/
504.Kanagaraj, P., et al. Multiple sclerosis and pregnancy. Obstet Gynaecol, 2019. 21: 177.
https://obgyn.onlinelibrary.wiley.com/doi/abs/10.1111/tog.12576
505.Bove, R., et al. Management of multiple sclerosis during pregnancy and the reproductive years: a systematic review. Obstet Gynecol, 2014. 124: 1157.
https://pubmed.ncbi.nlm.nih.gov/25415167/
506.Przydacz, M., et al. Recommendations for urological follow-up of patients with neurogenic bladder secondary to spinal cord injury. Int Urol Nephrol, 2018. 50: 1005.
https://pubmed.ncbi.nlm.nih.gov/29569211/
507.Abrams, P., et al. A proposed guideline for the urological management of patients with spinal cord injury. BJU Int, 2008. 101: 989.
https://pubmed.ncbi.nlm.nih.gov/18279449/
508.Ineichen, B.V., et al. High EDSS can predict risk for upper urinary tract damage in patients with multiple sclerosis. Multiple Sclerosis, 2017. 1352458517703801: 01.
https://pubmed.ncbi.nlm.nih.gov/28367674/
509.Pannek, J., et al. Clinical usefulness of ultrasound assessment of detrusor wall thickness in patients with neurogenic lower urinary tract dysfunction due to spinal cord injury: Urodynamics made easy? World J Urol, 2013. 31: 659.
https://pubmed.ncbi.nlm.nih.gov/23073657/
510.Silva, J.A., et al. Association between the bladder wall thickness and urodynamic findings in patients with spinal cord injury. World J Urol, 2015. 33: 131.
https://pubmed.ncbi.nlm.nih.gov/24573904/
511.Veenboer, P.W., et al. Diagnostic accuracy of Tc-99m DMSA scintigraphy and renal ultrasonography for detecting renal scarring and relative function in patients with spinal dysraphism. Neurourol Urodyn, 2015. 34: 513.
https://pubmed.ncbi.nlm.nih.gov/24706504/
512.Ismail, S., et al. Prevalence, management, and prognosis of bladder cancer in patients with neurogenic bladder: A systematic review. Neurourol Urodyn, 2018. 37: 1386.
https://pubmed.ncbi.nlm.nih.gov/29168217/
513.Lewis, J., et al. A framework for transitioning patients from pediatric to adult health settings for patients with neurogenic bladder. Neurourol Urodyn, 2017. 36: 973.
https://pubmed.ncbi.nlm.nih.gov/27276694/